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     Obesity is a growing health concern in the United States and worldwide. The chronic, low 
grade inflammation associated with increased white adipose tissue mass has been linked to 
chronic metabolic disorders such as insulin resistance, hypertension, and hyperlipidemia. 
Consumption of high fat diets leads to intestinal disorders such as microbial dysbiosis and gut 
barrier dysfunction that can adversely impact systemic metabolism. One potential dietary strategy 
to alleviate the high fat-induced chronic inflammation is increased consumption of fruits and 
vegetables rich in polyphenols due to their antioxidant and anti-inflammatory properties.  
Notably, several studies have demonstrated that supplementation with grape products or 
anthocyanins found in grapes reduced inflammation systemically and increased the abundance of 
beneficial bacteria such as Lactobacillus, and Bifidobacterium in culture.  However, the 
beneficial properties of whole grape powder and one or more of its fractions on intestinal 
inflammation, microbial populations, and barrier function in mice fed an American type diet rich 
in saturated fat are unclear. 
     Therefore, the specific aims of this research were to; (i) determine the impact of consuming 
California table grapes on intestinal health in mice fed an American type diet rich in one type of 
saturated fat (Aim 1), and (ii) identify a key fraction (i.e., extractable polyphenol (EP) or non-
extractable polyphenol (NEP) fractions) of California table grapes that improves markers of 
intestinal inflammation in mice fed an American type diet rich in four types of saturated fats (Aim 
2). In Aim 1, consumption of the powder grape diet; (i) reduced body fat percentage, the total 
weight of all four fat depots, and inguinal fat depot weight, (ii) increased localization of a tight 
junction protein linked to improved barrier function, (iii) reduced the abundance of a deleterious 
sulfidogenic bacteria, and (iv) increased the abundance of beneficial bacteria (e.g., Akkermansia 
muciniphila, Bifidobacterium, and Lactobacillus), compared to high fat controls. However, the 
high fat diet did not significantly increase the abundance of inflammatory markers in the intestine 
nor did the powdered grapes significantly decrease their abundance.  Taken together, these data 
acquired in Aim 1 demonstrate that whole powdered California table grapes improved a marker 
of gut barrier function and a metabolic profile that was positively correlated with changes in 
microbiota in mice fed a butter-rich diet. In Aim 2, the polyphenol-rich EP fraction alone or in 
combination with NEP (EP+NEP), but not unfractioned powdered grapes; (i) decreased body fat 
percentage, body fat depot weights, and liver triglyceride levels, (ii) improved insulin sensitivity 
and glucose disposal, (iii) decreased the mRNA levels of several inflammatory genes in WAT, 
and (iv) decreased the expression of the proinflammatory gene Cluster of differentiation 68 in the 
colon. Taken together, these data demonstrate that the; (i) potential health benefits of consuming 
grape powder are dependent on the type and amount of fat in the diet, and (ii) extraction of 
polyphenols from powdered grapes results in improved metabolic profile and decreased systemic 
inflammation in conjunction with consuming a rich in saturated fats.  Collectively, these findings 
are expected to contribute insight for the development of dietary strategies using table grapes for 
decreasing obesity and some of its metabolic complications, possibly by altering populations of 
gut microbes.  However, clinical trials are needed to determine the extent to which these findings 
are applicable to humans.      
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CHAPTER I 
INTRODUCTION 
Overview 
     Obesity is a growing health issue, affecting approximately 11% of the world’s population and 
36% of Americans [1, 2]. Sedentary lifestyle and excessive calorie intake of foods and beverages 
high in sugars or fats, especially saturated fat, are believed to be the main environmental causes 
for this disease state [3]. Obesity is of particular concern, because of its comorbidities including 
type 2 diabetes, hyperlipidemia, and hypertension.  
     Foods containing indigestible carbohydrates commonly referred to as fiber and bioactive 
components such as phytochemicals have been shown to reduce some of the deleterious 
conditions associated with obesity. For example, grapes contain numerous phytochemicals 
including flavonols, anthocyanins, flavan-3-ols, and hydroxycinnammic acids which have been 
reported to have antioxidant and anti-inflammatory properties that may alleviate oxidative stress 
and insulin resistance associated with chronic, low grade inflammation [4, 5]. In addition to 
phytochemicals, grapes contain fiber, an indigestible food component that has been shown to 
increase butyrate-producing bacteria, which in turn improves intestinal health by enhancing 
barrier function [reviewed in 6]. However, little is known about the potential benefits of grapes 
on intestinal microbiota abundance, inflammatory status, or barrier function in mice consuming 
an American type diet rich in saturated fat. 
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Central Hypothesis and Specific Aims 
     The long term goal of our research group is to develop innovative dietary strategies designed 
to control chronic, low-grade inflammation commonly associated with diet-induced obesity using 
California table grapes. The central hypothesis for my thesis is that intestinal inflammation and 
impaired gut barrier function associated with diets high in saturated fats will be attenuated by 
dietary intervention with California table grapes through the modification of intestinal microbiota 
and inflammatory status as shown in the working model (Fig. 1.1). Our group is well prepared to 
carry out this research due to our experience; (i) in laboratory animal husbandry protocols, (ii) 
live animal testing procedures, and (iii) tissue analyses including RNA isolation, cDNA synthesis, 
qPCR, immunoblotting, and enzyme assays, thereby ensuring minimization of errors in data 
collection. Our collaborators at the University of Illinois are Dr. H. Rex Gaskins and graduate 
assistant Patricia Wolfe, experts in microbiota analyses and culturing probiotics. Our 
collaborators at the North Carolina Research Campus in Kannapolis are Drs. Mary Ann Lila and 
Mary Grace, experts in fractionating and identifying fruit polyphenols, and Drs. Zhan Zhou and 
Wei Zong, experts in assessing gut barrier function. Our collaborators at the University of 
Chicago are Drs. Kristina Martinez, Eugene Chang, and Chase Cockrell, experts in microbiota 
and short chain fatty acid (SCFA) analyses.  
     To test my hypothesis, I will pursue the following two specific aims:  
Aim 1.  Determine the impact of consuming California table grapes on intestinal health in 
mice fed an American type diet rich in one type of saturated fat; and 
Aim 2. Identify a key fraction of California table grapes that improves markers of intestinal 
inflammation in mice fed an American type diet rich in four types of saturated fats. 
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     Based on my review of the current literature, the ability of California table grapes, the most 
abundantly-grown table grapes in the U.S., to suppress intestinal inflammation and improve 
barrier function in mice fed an American type diet has not yet been examined. Furthermore, the 
bioactive fraction in table grapes responsible for these potential gut health-promoting actions and 
their impact on goblet cell function is unknown, and the impact of these grapes on gut microbiota 
has not been published. Thus, completion of my aims will lead to the following anticipated 
outcomes; (i) powdered grapes will attenuate gut inflammation in high fat fed mice, as well as 
increase the number of butyrate-producing bacteria while reducing the number of sulfidogenic 
bacteria, and (ii) a polyphenol-rich, bioactive fraction (i.e., containing extractable polyphenols) in 
table grapes will be identified that reduces adiposity and improves glucose tolerance in 
association with reducing intestinal inflammation. These proposed improvements will be 
associated with modifications in mucosal microbiota (i.e., decreasing sulfidogenic bacteria and 
increasing butyrate producing bacteria (i.e., Bifidobacterium) or Akkermansia muciniphila, (a 
health-promoting microbe), and upregulation of G-protein receptors (i.e., GPR-41,-43, or -119) 
associated with improved metabolic profiles. 
     Completion of this research will further our understanding of how California table grapes act 
as prebiotics that improve gut health and subsequent metabolic complications associated with 
consuming a diet rich in saturated fat. Such knowledge will inform the public about the gut 
health-promoting properties of California table grapes; a nutritionally and economically important 
agricultural products in the U.S.  
Significance  
     Diets high in fats and calories lead to obesity and are associated with chronic, low-grade 
intestinal inflammation and alterations in the intestinal microbiota [reviewed in 7]. My research 
will demonstrate that powdered California table grapes will attenuate the deleterious changes 
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associated with consuming diets rich in saturated fatty acids. The research proposed in this study 
is significant, because application of the results and new knowledge gained are expected to lead 
to new dietary approaches using California table grape products to reduce intestinal inflammation 
with improvements in intestinal and systemic health. These proposed outcomes have the potential 
to reduce health care costs and loss of productivity associated with obesity and its comorbidities.  
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Figure 1.1. Working Model.  Powdered grapes attenuate inflammatory signaling, endotoxemia, 
and metabolic dysfunction in mice consuming an American diet rich in saturated fats by; (i) 
increasing butyrate-producing bacteria and Akkermansia muciniphila (A. muciniphila) which 
enhance goblet cell secretion of mucin and barrier protein synthesis in colonocytes, (ii) reducing 
intestinal inflammation which will prevent gut permeability, (iii) attenuating the growth of 
sulfide/sulfate reducing bacteria which produce the cytotoxic gas hydrogen sulfide that increases 
gut inflammation and permeability.  
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CHAPTER II 
REVIEW OF LITERATURE 
 
 
Obesity and the Consequences of Chronic Increases of Inflammatory Genes  
     An estimated 1.4 billion people over the age of 20 are over-weight and an additional 500 
million are considered obese worldwide [1]. As of 2010, an estimated 69% of the United States’ 
adult population was considered overweight or obese (36%) [2]. Consumption of high calorie 
diets and sedentary lifestyles are two major causes of obesity. Obesity or excess body fat is 
defined as having a body mass index (BMI) >30 [3]. The health risks of obesity include high 
blood pressure, type 2 diabetes, and hyperlipidemia, which have been referred to as the metabolic 
syndrome [3].  
     An important linkage between obesity and its associated health risks is chronic, low-grade 
inflammation. One mediator of inflammation is tumor necrosis factor alpha (TNF-α), which has 
been shown to cause insulin resistance in muscle and white adipose tissue (WAT) [4, 5]. TNF-α 
is a cytokine produced by immune cells and adipocytes that increases insulin resistance via 
inhibition of insulin signaling cascades needed for glucose uptake and utilization [6]. Notably, 
TNF-α expression is elevated in WAT and muscle of human and animal obesity models [7, 8]. 
Consistent with these data, TNF-α knockout mice fed high fat diets did not develop insulin 
resistance [9]. Thus, TNF-α is a pro-inflammatory cytokine associated with increased WAT that 
contributes to some of the health risks associated with obesity.  
     Obesity is typically accompanied by increased macrophage recruitment within WAT. This 
recruitment not only increases the secretion of cytokines, inducing further inflammation, but is 
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also involved in tissue remodeling [10]. As adipocytes increase in size in order to compensate for 
increased triglyceride (TG) synthesis from excessive glucose and fatty acid uptake, they become 
abnormally large, overstressing the collagen matrix and vasculature of the tissue [11]. These 
changes result in decreased angiogenesis, hypoxia, and adipoapotosis in WAT, leading to the 
macrophage recruitment designed to clean up necrotic adipocytes in WAT.  
     Increased gene expression and secretion of interleukin-6 (IL-6) and monocyte chemoattractant 
protein (MCP-1) are further examples of pro-inflammatory cytokines released by expanding 
adipocytes [12]. The increase in IL-6 results in an increase in c-reactive protein (CRP), which is a 
cytotoxic, acute phase protein. MCP-1 increases adipocyte inflammation through recruitment of 
classically-activated macrophages (i.e., M1) which cause the release more pro-inflammatory 
cytokines including CRP, cluster of differentiation 11c (CDllc), and enzyme inducible nitric 
oxide synthase (iNOS).  
     The increased expression of inflammatory peptides or proteins is initiated by an inflammatory 
kinase cascade. Inflammatory mediators such as inflammatory cytokines and lipids, endoplasmic 
reticulum (ER) stress, and reactive oxygen species (ROS) activate mitogen-activated protein 
kinases (MAPK)s, c-Jun N-terminal kinase (JNK) and IkB kinase (IKK) [13]. JNK and IKK 
modulate a phosphorylation signaling cascade resulting in the activation of transcription factors 
activation protein-1 (AP-1, aka cJun) and nuclear factor-kappa B (NF-κB), respectively. 
Activation of these transcription factors leads to an increase in the expression of the inflammatory 
cytokines, exacerbating the inflammatory response. Hyperglycemia and hyperlipidemia due to 
excess energy consumption increases mitochondrial metabolism leading to an increase in ROS 
production. ER protein synthesis is also increased in response to mitochondrial need and 
metabolic stress, resulting in ER stress. Increasing JNK and IKK may also inhibit insulin receptor 
substrate activation via serine phosphorylation, resulting in insulin resistance [14].  
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     Other tissues are also affected by the excessive caloric intake. For example, skeletal and 
cardiac muscle tissue can experience an increase in free fatty acids (FFA) uptake when blood 
levels are elevated, resulting in ectopic deposition in these tissues [reviewed in 15]. As in WAT, 
this leads to an overload of the capacity of ER to metabolize FFAs, leading to an increase in 
ceramide and diacylglycerol and an inflammatory cascade similar to WAT, resulting in insulin 
resistance. Increased incorporation of lipids and cyto-chemokine signaling in endothelial cells 
also leads to increased macrophage accumulation of lipids, resulting in the development of foam 
cells, compromised blood flow, and cardiovascular disease [16]. Lastly, ectopic accumulation of 
lipids in pancreas can impair insulin secretion, thereby reducing insulin-stimulated glucose uptake 
and utilization.  
 
Relationship between Systemic and Intestinal Inflammation  
     Although systemic inflammation has been a primary focus in research involving obesity, the 
effects of increased WAT on intestinal inflammation, and vice versa, have more recently been 
recognized. Along with instigating chronic, low grade inflammation systemically, diets high in 
fats also impact intestine health. However, the relationship between WAT and intestinal 
inflammation due to diet-induced obesity is unclear; i.e., does obesity cause WAT inflammation, 
which in turn, causes intestinal inflammation and barrier dysfunction, or does intestinal dysbiosis 
and inflammation due to high fat feeding cause endotoxemia, increased energy harvest, WAT 
expansion, and inflammation? These questions are currently being debated. Whereas some 
studies indicate that obesity triggers the release of inflammatory signals from WAT that influence 
the intestinal tract [17], others indicated that high fat diets trigger intestinal inflammation or 
endotoxemia, that causes systemic inflammation, possibly due to intestinal barrier dysfunction. 
For example, activation of the Toll-like receptor 4 (TLR4)/NF-κB signaling pathway by saturated 
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fatty acids or lipopolysaccharide (LPS) increases TNF-α and IL-6 expression in intestinal tissue 
of high fat fed mice [18]. High fat diets have also been shown to modulate the ratio of immune 
cells produced by intestinal lymphocytes [19]. In particular, mice fed a high fat diet were more 
susceptible to dextran sulfate sodium (DSS) induced colitis due to an increase of non-CD1d-
restricted natural killer T (NK T) cells as opposed to regular NK T cells in the colon. Non-CD1d-
restricted NK T cells produce inflammatory cytokines similar to those expressed in adipocytes 
leading to an increased susceptibility of colon mucosa to a DSS insult, whereas regulatory T cells 
would protect against such an insult reducing the occurrence of colitis.  
 
Gut Barrier Function and the Role of Gut Microbiota 
     The landscape of the gastrointestinal (GI) tract is one of constant change. Diet composition 
and microbiota-sensing proteins like TLR4 signal not only for modulation of gene and protein 
expression, but also for the differentiation of epithelial cells. Crypt cells utilize these signals to 
differentiate epithelial stem cells into enterocytes, goblet cells, enteroendocrine cells, or 
antimicrobial peptide secreting cells (e.g., paneth cells), based on the need for increased 
absorption, physical barrier, chemoreceptors, or microbial regulation, respectively [reviewed in 
20]. Despite the constant turnover of epithelial cells, which allows for continuous migration of 
cell types to areas of need, all of the cell types display tight junction proteins such as claudin-1, 
occludin-1, or zonula occludens (ZO)-1, forming an effective barrier between cells [21]. Just as 
the adaptability of epithelial cells and tight junctions between them are meant to be protective 
mechanisms against the entry of pathogens and deleterious compounds (i.e., bacterial LPS, DNA, 
or peptidoglycan)  into the bloodstream resulting in endotoxemia), so are the secretions of goblet 
cells.  
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     Goblet cells form and secrete mucin glycoproteins and mucins, which create a bilayer lining 
the intestine [22]. The inner layer closest to the enterocytes prevents the passage of pathogens 
into the enterocyte. The outer layer is more loosely connected creating a homeostatic environment 
suitable for bacterial attachment and growth [23]. The benefits of mucins have been demonstrated 
in the development of ulcerative colitis in mucin 2 (MUC2)-depleted mice [24].  
     Similar to constant epithelial cell turnover, the composition of the microbiota fluidly changes 
depending on the available dietary substrates consumed and changes in pH resulting from the 
level of acidic byproducts generated [reviewed in 25]. Thus, the symbiotic relationship between 
the endothelial cells and microbes can be disrupted by adverse environmental changes such as 
high fat diets (Table 2.1). Dysfunction of this system is represented by increased plasma, urine, 
and fecal endotoxin levels, as well as markers of inflammation in the gut including the 
macrophage recruiter monocyte chemoattractant protein (MCP-1) and TLR4. However, dietary 
changes to the gut microbiome may be independent of such dysfunctions or obesity.  For 
example, Sprague Dawley rats fed a high fat diet were categorized as obesity-prone or obesity-
resistant. Regardless of their designation, all high-fat-fed rats exhibited a reduction in total 
microbial density with an increase in Bacteriodales and Clostridales.  However, obesity-prone 
rats exhibited an increase in intestinal markers of inflammation and reduction of gut barrier 
function leading to increased levels of plasma LPS.  Thus, microbial alterations were independent 
of increased inflammation and obesity. Of greater concern is the development of endotoxicity.  
     Endotoxicity is represented by an increase in serum levels of lipopolysaccharide (LPS), a cell 
wall component of gram negative bacteria, demonstrating microbial inflammation and 
compromised barrier function. This was demonstrated in research involving TLR4-deficient and 
normal mice [27]. Both normal and TLR4-deficient mice fed a high fat diet showed alterations to 
the gut microbiome through an increase in the ratio of Firmicutes to Bacteriodetes, primarily 
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through an increase in Enterobacteriaceae, a gram-negative bacterial family, which coincided 
with an increase in intestinal inflammation and impairment of gut barrier function compared to 
low fat controls [27]. The high-fat-fed mice also had increased systemic inflammatory markers 
including those related to endotoxicity compared to low-fat-fed mice. The TLR4-deficient mice 
had a similar increase in body weight compared to the wild type, high-fat-fed mice. However, 
epididymal tissue weight, and plasma endotoxin levels were significantly decreased in 
conjunction with the TLR deficiency, demonstrating a correlation between TLR4-mediated 
inflammation and increased adiposity and endotoxemia.  Thus, the impact of diet on gut 
microbiota has a major effect on systemic inflammation.  
 
Association of Gut Microbiota with Chronic Disease States 
     Research has attempted to determine potential mechanisms by which microbiota modulate 
intestinal inflammation (Table 2.1). Primarily, there are indications that a correlation exists 
between CD4
+
 T, Th1, and Th17 cell response to antigens produced by bacteria and chronic 
intestinal inflammation associated with inflammatory bowel disease (IBD) [reviewed in 28].  
These immune response cells are activated by specific stimuli associated with commensal 
bacteria and their abundance may be increased in healthy GI tracts.  
     The development of diseases associated with chronic inflammation  may be the result of 
alterations in commensal populations as opposed to introduction of a pathogenic strain.  Recent 
research using ulcerative colitis mouse models, which developed intestinal dysbiosis, 
demonstrated modular increases in Enterobacteraciae, Klebsiella pneumonia, and Proteus 
mirabalis, that induced colitis when transferred to wild-type mice [29, 30].  IL-10 deficient 
gnobiotic mice monoassociated with nonpathogenic strains of either Escherichia faecalis or E. 
coli induced colitis, whereas similar monoassociation with wild type gnobiotic mice did not.  
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Interestingly, alterations in the colitis phenotypes were observed to be dependent on the strain.  E. 
faecalis induced slower onset with predominant colitis in the colon whereas E. coli induced a 
quicker onset predominating in the cecum [31, 32].   
     Such results may give some indication as to the association between location of site-specific 
IBD and certain bacterial blooms.  Patients with Crohn’s disease in particular have notably 
reduced microbial diversity, yet an increase in epithelial surface colonization and infiltration [33].  
Indeed, certain bacteria dominate these colonizations depending on the sight of inflammation as 
demonstrated by the decrease in Faecalibacterium and Rosburia and increase in 
Enterobacteriaceae and Ruminococcus gnavus populations associated with Ileal Crohn’s Disease. 
In another study biopsies of intestinal tissue of patients with ulcerative colitis and Crohn’s disease 
compared to healthy controls demonstrated that Proteobacteria and Bacteroidetes were 
significantly increased by Crohn’s disease while Clostridia were decreased compared to healthy 
and ulcerative colitis patients [34].  These increased bacterial populations associated with IBD are 
primarily commensal bacteria that normally do not produce inflammation.  Thus, it is suspected 
that a genetic component is also involved.  Indeed, the majority of genetic risk factors associated 
with IBD encode for proteins involved in sensing the microbial environment (e.g., nucleotide-
binding oligomerization domain containing 2), host immune response elements (e.g., the IL-12- 
IL-23R pathway), and gut barrier function [reviewed in 35].   
     Like IBD, non-alcohol fatty liver disease may be caused by endotoxicity resulting from 
impaired gut barrier function. A correlation has been found between obesity due to high-fat 
intake, alterations in gut microbiota, and associated intestinal permeability and non-alcohol fatty 
liver disease [reviewed in 36].  Although non-alcohol fatty liver is associated with obesity, not all 
obese individuals develop this condition.  This may be due, in part, to individual variability of the 
host microbiome.  Indeed, evidence in animal and human studies suggests that choline dependent 
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bacteria may have a great impact on this disease state [37, 38].  In both cases, the increase of 
choline dependent bacteria such as Gammaproteobacteria and Erysipelotrichi, resulted in 
conversion of choline to methylamines creating a choline depleted environment.  In such cases, 
liver steatosis increased, providing further evidence to the causal link between microbiota and 
liver disease.  
     As inflammation progresses, it results in nonalcoholic steatohepatitis and liver cirrhosis.  As 
such, the level of cirrhosis has been shown to be correlated with increased levels of LPS, resulting 
in activation of nitric oxide modulated enzymes [reviewed in 36]. Furthermore, cirrhosis is 
evidenced by a depressed endothelial defense system as a result of bacterial translocation.   
  
Impact of Diet on Gut Microbiota and the Potential Influence on Host Health 
     Several studies have linked high-fat feeding to remodeling of microbial populations in the GI 
tract (Table 2.1). The most common outcome of these high-fat-feeding studies is an increase in 
Firmicute/Bacteroidete ratio in obese subjects [39-41]. This led to an increase in energy 
harvesting (e.g., increase in short chain fatty acid (SCFA) absorption) and a corresponding 
increase in adiposity. Germ-free mice inoculated with microbes from obese mice had 
significantly increased fat accumulation with no dietary modification; further supporting the 
concept that changes in gut microbes influences the development of obesity [39]. An acute 
inflammatory response due to the increase in Firmicute/Bacteroidete ratio has also be correlated 
with a significant increase in the levels of CRP and fecal calprotectin, two proteins secreted in 
response to pathogenic inflammation [40].  
     Other indicators of microbiota influence on inflammation in C57BL/6J mice fed high fat, low 
carbohydrate diets include lower expression levels of intestinal tight junction proteins and 
increased markers of WAT inflammation and body fat compared to low-fat-fed controls [41-43]. 
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Furthermore, several research studies have demonstrated that changing the diet from high fat to 
low fat has a quick, positive effect on the composition of microbiota and subsequent intestinal 
inflammation [44, 45]. This demonstrates not only the adaptability of the microbiota to dietary 
changes, but also that of epithelial integrity and immune response systems. Indeed, dietary 
changes can induce complete changes in the gut microbiota in as little as 24 hours after dietary 
change [46].  
     Emerging research has linked products of microbiota metabolism as a primary cause for 
changes in intestinal integrity and inflammation. Such metabolic products are influenced by 
dietary components. For example, hydrogen sulfide is a byproduct of some intestinal microbes 
such as Bilophila wadsworthia and Desulfovibrionaceae that has emerged as a major deleterious 
compound associated with high-fat-feeding [47, 48]. Increased hydrogen sulfide resulted in 
decreased gut barrier function, increased immune response, and reduction of gut-barrier 
protecting bacteria, like Bifidobacterium [48]. Indeed, multiple studies have shown a positive 
correlation between increased hydrogen sulfide and development of ulcerative colitis, gut 
inflammation, IBD, and colon cancer [47-49]. This is due, in part, to the cytotoxic nature of 
hydrogen sulfide on colonocytes, leading to increased turnover, along with reductions in butyrate 
oxidation [50-52].  
     Milk fat, but not lard or polyunsaturated fat, increased Bilophila wadsworthia populations, 
which was associated with increased incidence of colitis [48]. This was primarily due to higher 
hepatic taurocholic acid production, a preferred substrate for sulfidogenic bacteria. Thus, the type 
of fat has a marked effect on gut microbes and their metabolic products, which in turn, impact gut 
health. This is important to consider when designing dietary strategies to attenuate intestinal and 
systemic inflammation.  
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     Dietary compounds that pass through the upper GI unabsorbed become potential substrates for 
gut microbes. Resistant carbohydrates are a class of potential substrates for fermentation that 
impact gut microbiota and their metabolic products (Fig. 2.1). Resistant starches, non-starch 
polysaccharides, and oligosaccharides make up what is commonly referred to as fiber. The 
resultant fermentation of these substrates leads to production of volatile SCFAs, CO2, H2, and 
formate [53]. The SCFAs most abundantly produced are acetate, propionate, and butyrate. The 
acidic nature of these products reduces intestinal pH throughout the lower GI, potentially 
preventing the growth of pathogenic bacteria (i.e., Enterobacteraciae) [54, 55]. This effect on pH 
may also be a determining factor on which class of fermenters predominate. At more neutral pH 
(6.5), acetate producers predominate whereas in a more acidic environment (pH 5.5), butyrate 
producers predominate [56]. Indigestible oligosaccharides facilitate a lower pH allowing butyrate 
producers to compete for substrates more efficiently than acetate or propionate producers that 
have slower growth [57].  
     The majority of SCFAs absorbed by gut epithelial cells are metabolized and the rest enter the 
hepatic-portal circulation. For example, butyrate is the primary energy source for endothelial 
cells, whereas propionate is sent to the liver where it is used as a substrate for gluconeogenesis 
[58]. Aside from being potentially the preferred energy source of enterocytes, butyrate also 
increases goblet cell gene expression, including MUC2 [59], and inhibits NF-κB signaling 
thereby reducing inflammation [60, 61].  Acetate can be used by the liver and WAT as a substrate 
for triglyceride (TG) or cholesterol biosynthesis.  Lactate is another fermentation product that is 
primarily utilized as a substrate for other bacteria [62, 63], or converted to other SCFAs. 
Increased butyrate production has multiple beneficial effects on intestinal integrity (i.e., increased 
gut barrier protein synthesis and mucin secretion that improve gut barrier function, reduce 
endothelial cytokine production, and regulate intestinal inflammation). 
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     Polyphenols are naturally occurring phytochemicals in plants that have been shown to enhance 
a number of biological activities, in particular those involved in the suppression of inflammation 
and oxidative stress and carcinogenesis [reviewed in 64].  Polyphenols are powerful antioxidants, 
having been shown reduce levels of ROS, reactive nitrogen species, hydrogen peroxide, and nitric 
oxide. Reducing pro-oxidants, in turn, decreases pro-inflammatory signaling pathways [64]. In 
addition, polyphenols exhibit apoptosis signaling properties that have been linked to cancer 
prevention.  In vitro studies using breast and pancreatic cancer cell models have shown that 
resveratrol and epicathicans from red wine promoted apoptosis through several signaling 
pathways, thus reducing the proliferation of the cancer cells in culture [65, 66]. Polyphenols have 
also been shown to inhibit inflammatory processes and microbial infiltration into intestinal cells.  
For example, pomegranate extract inhibited NF-κB activity in human epithelial colorectal 
adenocarcinoma (Caco2) cells, reducing the level of secreted cytokines [67]. Similarly, geinstein 
prevented enteric bacteria from entering Caco2 and HT-29 cells, a human colorectal 
adenocarcinoma cell line [68]. Although polyphenol absorption can be detected almost 
immediately and peak concentrations occur as quickly as 2 hours post-ingestion [69], the relative 
abundance in circulation is very low compared to dietary intake and urinary excretion levels 
[reviewed in 70].  However, known metabolites of polyphenols can be detected in greater 
concentrations systemically and in feces with different kinetic profiles, indicating that 
bioaccessibility and bioavailability are complex processes involving multiple stages of liberation, 
primarily by microbial enzymes prior to their absorption, distribution, and excretion [71].   
     Over 90% of dietary polyphenols are not absorbed in the upper GI and thus persist in the lower 
GI tract [reviewed in 72]. This is primarily the result of low concentrations of polyphenols within 
the food and enzymes necessary to metabolize polyphenols into more readily absorbable forms 
(Fig. 2.2).  Naturally occurring polyphenols require deconjugation in order to diffusion into the 
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enterocyte [72].  The brush border of the small intestine contains membrane bound β-
glucosidases which facilitate the process for hydrolyzing gluconated polyphenols into absorbable 
aglycones [73].  Once within the enterocyte, the aglycone will either undergo Phase I (e.g., 
reduction, oxidation, or hydrolysis) and II (e.g., conjugation) metabolism immediately, converting 
them into methyl-esters, glucuronides, and sulfates primarily, or be transferred to the liver to 
undergo similar metabolism [reviewed in 73]. Conjugating aglycones reduces their potential 
microbial toxicity, while also making them easier to transport as biotransformed polyphenols. 
Subsequently, they may enter the systemic circulation where they may interact with other tissues, 
be excreted in the urine, or become bound to bile acids and redistributed back into the intestine 
following release from the gall bladder [reviewed in 71]. Those polyphenols that are easily 
absorbed may play some role in the observed health benefits; however,  their health benefits are 
more likely the result of their interaction with gut microbiota. 
     Because the majority of polyphenols persist to the distal small intestine and colon, it is 
believed that their interactions with the gut microbiota play a greater role in health promotion and 
disease prevention (Fig. 2.2) [71]. Polyphenols exhibit similar effects on the luminal environment 
as previously reported with fiber, including reducing pH, thereby impacting the growth of some 
bacteria while also being a substrate for bacterial fermentation [reviewed in 74].  Research has 
demonstrated that bacteria, primarily gram-negative anaerobes, are able to metabolize most 
polyphenols regardless of complexity or conjugation through the use of a variety of enzymes 
(e.g., esterase, glucosidase, glycosidase, dehydroxylation, decarboxylation, demethylation, and 
ring fission activity) into generalizable metabolites (e.g., acetate, propionate, butyrate, gallic acid, 
hippuric acid, ferulic acid) [75-78]. Aside from their influence on pH, polyphenols also exhibit 
other antibacterial properties (i.e., inhibit quorum sensing [79], disrupt lipid membrane integrity 
[80] and DNA polymerase activity [81], and alter protein synthesis priority from metabolism to 
19 
 
protection [82]). As such, polyphenol metabolism to non-toxic byproducts may be a defense 
mechanism.  Nevertheless, the presence of polyphenols and their metabolites may have beneficial 
effects on the gut microbiome and host health. 
     The ability of some microbes to metabolize polyphenols and antibacterial properties exerted 
on others demonstrate their prebiotic potential (Fig. 2.2).  Caco2 cells in a mix batch culture 
media treated with quercetin and naringen reduced the adhesion of S. aureus while improving the 
growth of Lactobacillus [83].  Pomegranate extract supplemented in high-fat-fed Balb/c mice 
increased Bifidobacterium levels in the cecum, which correlated with decreased inflammation in 
the colon and visceral adipose tissue [84].  Similarly malvindin-3-glucosides, gallic acid, and a 
mixture of anthocyanins enhanced the growth of Bifidobacterium and Lactobacillus-
Enterococcus bacteria [85]. Indeed human males given a proanthocyanin-rich extract had a 
dramatic shift in fecal microbial populations from Bacteriodes, Clostridium, and 
Propionibacterium phyla to Bacteriodes, Lactobacillus, and Bifidobacterium predominance [86].  
Taken together these studies strengthen the concept that polyphenol consumption effectively 
reduces deleterious bacteria while promoting beneficial bacteria. In addition to the observed 
prebiotic effects, microbial metabolism of polyphenols has a positive influence on host health.   
     As previously mentioned in regards to fiber, polyphenol metabolism may produce byproducts 
beneficial not only to microbiota homeostasis, but also to host health. Metabolites tested in vitro 
have been shown to consistently inhibit iNOS, cycolo-oxygenase-2, IL-1β, IL-6, TNF-α, as well 
as preform as antioxidant and antiproliferative agents [reviewed in 71].  The ring cleavage of 
flavonoids into SCFAs similar to fermentation of fiber, has the same beneficial effects on energy 
intake, metabolism regulation, and improvements to epithelial health and integrity [87].  Other 
metabolites such as gallic acid, hippuric acid and ferulic acid are less likely to be utilized as a 
substrate by bacteria and thus are more readily absorbed into the systemic circulation.  In vitro 
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testing of the degradation of gallic acid compared to anthocyanins in a model representing colonic 
bacterial cultures showed that anthocyanins were completely degraded within 5 hours while gallic 
acid remained in measureable concentrations for 24 hours [85]. Human subjects given an 
anthocyanin supplement had 17 distinguishable metabolites recognized within their serum that 
have a wide range of kinetic profiles, demonstrating that metabolites of polyphenols can exist 
long after the initial peak observed when measuring the levels of the polyphenol itself [88]. Taken 
together, these results as well as previously mentioned results involving polyphenols and fiber 
suggest that foods particularly berry fruits including grapes, containing bioactive compounds that 
can have a positive impact on intestinal and systemic health through their interactions and 
influence on the intestinal microbiome.        
  
Anti-inflammatory Properties of Grapes  
     Grapes and their byproducts are commonly consumed throughout the world. Grapes contain 
nutrients such as water, carbohydrates, fats, vitamins, minerals, and fiber as well as bioactive 
phytochemicals, particularly polyphenols [reviewed in 89]. The phytochemicals and the fiber 
components of grapes have been hypothesized to attenuate diet induced, chronic inflammation 
and pro-oxidants [reviewed in 89]. The phytochemicals in grapes include flavonoids, (pro) 
anthocyanidins/anthocyanins, and stilbenes [89]. Grapes also contain fiber in the form of 
cellulose, pectin, and various fructans (e.g., fructo-oligosaccharides, disaccharides, and 
polysaccharides), which are the main indigestible carbohydrate component of grapes [90, 91].  
     Anthocyanins are the most abundant polyphenol group in grapes and many other berries 
[reviewed in 90]. In vitro studies have demonstrated that anthocyanins reduce ROS and insulin 
resistance in adipocytes exposed to hydrogen peroxide or TNF-α [92]. Consumption of 
anthocyanin-rich tart cherry powder reduced adiposity, WAT NF-κB activity, and serum TNF-α 
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and IL-6 levels in high fat fed rats [93]. Mice fed anthocyanin-rich blueberry powder had reduced 
levels of inflammation markers, oxidative stress, and insulin resistance compared to controls [94]. 
Flavanols, primarily quercetin, kampferol, rutin, and isorhamnetin, have also been shown in vitro 
to reduce oxidative stress in multiple cell types exposed to several inflammatory compounds [95-
99]. In vitro testing of liver cells exposed to a cytokine mixture demonstrated that quercetin and 
kaempferol attenuated an increase in ROS and oxidized glutathione, demonstrating their ability to 
suppress pro-oxidants [95]. Rutin has been shown to reduce inflammatory gene expression in 
epithelial sepsis cell models [96]. Similar results were seen in mice treated with quercetin; i.e., 
quercetin treatment in mice fed a high fat diet lowered mRNA levels of pro-inflammatory IL-6, 
CRP, MCP-1, and acyloxyacyl hydrolase in liver tissue compared to high fat controls [97]. 
Isorhamnetin, a metabolite of quercetin, reduced LPS- induced oxidative stress in rats [98]. 
Intestinal colitis was attenuated by concentrated grape juice in Wistar rats, with flavonoids being 
the proposed facilitators of these beneficial changes in gut health [99].  
 
Potential Prebiotic Properties of Grapes  
     To date, the prebiotic effects of California table grapes have not been explored.  However, 
studies have been conducted on grape products, extracts, and polyphenols including quercetin, 
fructo-oligosacharrides, and grape juice. Inoculation of Lactobacillus acidophilus and plantarum, 
two probiotic bacteria, with quercetin plus fructo-oligosacharrides increased their growth 
compared to controls [100]. Fructo-oligosacharride has also been shown to enhance the growth of 
butyrate-producing bacteria from Firmicute and Bifidobacterium families [101]. Several grape 
juice varieties have also demonstrated to have prebiotic effects by increasing the growth of L. 
acidophilus and L. delbruekii, two probiotic bacteria, while attenuating growth of E. coli in vivo. 
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[102]. However, the impact of California table grapes on intestinal health and its association with 
systemic health in diet-induced obesity has not been reported in the literature. 
     Grape polyphenols may have a major impact on the microflora of the large intestine.  Red 
wine grape polyphenols given to humans for 4 weeks significantly increased the number of 
Enterococcus, Prevotella, Bacteriodetes, and Bifidobacterium bacteria which were positively 
correlated to improved blood pressure, and serum concentrations of triglycerides, total 
cholesterol, and CRP [103].   F344 rats treated with wine polyphenols also had increased numbers 
of beneficial bacteria namely Bacteriodes, Lactobacillus, and Bifidobacterium [104].  Grape seed 
extract and wild blueberry supplementation increased Bifidobacterium levels [105, 106]. Further 
evidence of the prebiotic effects of grape consumption was demonstrated in rats given grape 
pomace juice, which increased fecal counts of Lactobacillus and Bifidobacterium and 
consequently resulted in an increase in the concentration of primary bile acids, cholesterol, and 
cholesterol metabolites while decreasing the concentration of secondary bile acids [107].  This 
indicates that alteration of the microflora by grape polyphenols may inhibit cholesterol 
absorption, thereby lowering circulating cholesterol levels.  Although these studies were 
conducted in humans and rats with wine grape, grape seed extract, and blueberries, there is reason 
to believe that similar results should be demonstrated in mice fed California table grapes.  
 
Summary and Gaps in the Literature  
     The rise in obesity is positively correlated with cardiovascular disease, type 2 diabetes, and 
hypertension via induction of chronic, low-grade inflammation. Overconsumption of calories 
relative to energy expenditure results in WAT expansion, hypoxia, and adipocyte death with 
subsequent production of inflammatory cytokines, chemokines, and adipokines. It also causes 
ectopic deposition of lipids in pancreas, liver, and muscle that further contribute to ER stress, 
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insulin resistance, hyperlipidemia, and inflammation. These metabolic outcomes of obesity are 
associated with macrophage recruitment, which further exasperates inflammatory signaling. 
Similarly, diet-induced obesity has been linked to intestinal inflammation, which has been 
associated with changes in populations of gut microbes. Such changes increase the production 
deleterious bacterial products that together reduce gut barrier function. Barrier dysfunction, in 
turn, allows translocation of inflammatory signals (e.g., bacterial LPS, DNA, and peptidoglycans) 
into the blood stream leading to endotoxemia and systemic inflammation. One potential strategy 
to reduce this inflammatory scenario associated with dietary obesity is to consume foods rich in 
indigestible carbohydrates and polyphenols that enhance intestinal health. Fructans such as 
fructo-oligosacharrides have been shown to promote enterocyte health by improving the 
composition of the microbiota (e.g., increasing butyrate producers and Akkermansia muciniphila 
and decreasing sulfidogenic bacteria) [81, 82]. Similarly, grapes and other berries have been 
shown to have anti-oxidant and anti-inflammatory properties due to their polyphenol abundance. 
Thus, many of the proposed beneficial systemic effects of consuming grapes may be due to their 
content of indigestible carbohydrates and polyphenols that positively influence intestinal health.  
     However, little is known on whether the concentration of fructans or polyphenols in California 
table grapes is sufficient to alter gut microbes. Furthermore, the impact of table grapes on 
intestinal inflammation has not been reported in the literature. In addition, the bioactive fraction 
of grapes responsible for these potential health benefits is not known.  
     Based on these gaps, I hypothesize that dietary intervention using whole powdered California 
table grapes will attenuate intestinal inflammation and improve gut barrier function associated 
with consuming diets high in saturated fat, and that these benefical effects will be associated with 
modifications of intestinal microbes. This hypothesis will be tested by pursuing the following two 
specific aims,  
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Aim 1.  Determine the impact of consuming California table grapes on intestinal health in 
mice fed an American type diet rich in one type of saturated fat; and 
Aim 2. Identify a key fraction of California table grapes that improves markers of intestinal 
inflammation in mice fed an American type diet rich in four types of saturated fat. 
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Table 2.1. Association between Gut Microbiota and Chronic Disease States
 
 
Desulfogenic Bacteria (DSB), hydrogen sulfide (H2S), tight junction protein (TJP), interleukin 
(IL), interferon (IFN), C-reactive protein (CRP), macrophage chemoattractant protein-1 (MCP-1), 
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toll-like receptor-4 (TLR4), lipopolysaccharide (LPS), white adipose tissue (WAT), nucleotide-
biding oligomerization domain containing 2 (NOD2), autophagy related 16-like 1 (Atg16l1), very 
low density lipoprotein (VLDL), trimethylamine (TMA), TMA-N-oxide (TMAO). 
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Figure 2.1. Impact of Microbial Fermentation of Fiber.  Non-digestible poly- and 
oligosaccharides are (1) depolymerized in the colon forming mono- and oligosaccharides.  
Anaerobic microbes within the colon digest these residues through fermentation forming (2) CO2, 
H2, formate, and short chain fatty acids (SCFA) such as., lactate, succinate, acetate, propionate, 
and butyrate. Acetate, propionate, and butyrate may be utilized as; (3) an energy source by other 
bacteria, (4) an alternative energy source for peripheral tissue, (5) free fatty acid receptor ligands 
(GPR41/43), (6) to reduce the luminal pH which inhibits the growth of most pathogenic bacteria.  
Activation of GPR41 and GPR43 on enteroendochrine L cells results in (7) the release of 
glucagon like peptides (GLP-1, GLP-2) and peptide YY (PYY), or on adipose tissue (GPR41) 
stimulates the release of leptin.  GLP-1 and PYY can (8) increase gut transit time leading to 
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increased nutrient absorption and potentially resulting in adipogenesis, or (9) in the presence of 
lepetin increase satiety thereby reducing nutrient intake. GLP-1 can also (10) stimulate the release 
of insulin and increase insulin sensitivity resulting in improved glucose uptake in muscle.  GLP-2 
improves intestinal immunity through (11) increasing gut barrier function and L cell number and 
improving microbial regulation.  Individually, acetate (12) increases triglyceride and cholesterol 
synthesis, propionate (13) increases gluconeogenesis and cholesterol synthesis in the liver, and 
butyrate (14) improves gut barrier function and mucin extretion, inhibits nuclear factor-Kβ 
inflammatory cytokine transcription, and it’s the prefered endothelial energy source. 
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Figure 2.2. Polyphenol Metabolism and Health Benefits.  Polyphenols are poorly absorbed and 
thus come in direct contact with gut microbes in the lower GI tract.  Although some polyphenols 
are deconjugated in the small intestine into aglycones, which may passively diffuse into the 
enterocyte, the majority persist to the distal small intestine and colon. Within the lumen, 
polyphenols can indirectly influence microbial populations through reducing the pH and 
hydrogen peroxide (H2O2) levels, while also chelating with unabsorbed metal ions, thus 
negatively influencing pathogenic and some gram-positive bacterial growth.  Polyphenols can be 
toxic to bacterial cells through disrupting normal cell properties, thus there are metabolized to 
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reduce the level of toxicity.  Some metabolites may be used as energy sources (e.g., SCFAs) 
promoting beneficial microbial growth, whereas others diffuse through enterocytes or interact 
within the enterocyte (having beneficial effects). Absorbed polyphenol metabolites and aglycones 
enter the liver through the portal vein before entering the systemic circulation.  Aglycones 
undergo further metabolism, once again becoming conjugated to make them easier to transport 
and excrete including transport back into the intestinal lumen via bile acid release from the gall 
bladder.  As polyphenols and metabolites travel through systemic circulation, they may interact 
with various tissues or be excreted in the urine.        
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Abstract 
 
     The objective of this study was to examine the extent to which consuming polyphenol-rich, 
California table grapes reduces adiposity, hepatic steatosis, markers of inflammation or lipid 
metabolism, or impacts gut microbiota in mice fed a butter-rich diet. Male, C57BL/6J mice were 
fed a low fat diet or butter-rich diet with or without 3% or 5% grapes for 11 weeks. Total body 
and inguinal fat content were reduced in mice fed both levels of grapes compared to their high-
fat, sugar controls. Mice fed 5% grapes had lower liver weights and triglyceride levels, and 
decreased hepatic expression of lipogenic glycerol-3-phosphate acyltransferase (Gpat1) compared 
to 5% controls. Mice fed 3% grapes had lower hepatic mRNA levels of the lipogenic genes 
peroxisome proliferator-activated receptor gamma 2, sterol-CoA desaturase 1, fatty-acid binding 
protein 4, and Gpat1 compared to 3% controls. In white adipose tissue (WAT), mice fed 5% 
grapes had decreased mRNA levels of the lipogenic gene acylglycerol-3-phosphate-O-
acyltransferase 2 compared to controls. Although grape feeding had only a minor impact on 
markers of inflammation in WAT or intestine, 3% grapes decreased the intestinal abundance of 
sulfidogenic Desulfobacter spp., and the Bilophila wadsworthia-specific dissimilatory sulfite 
reductase gene, and tended to increase the abundance of the beneficial bacterium Akkermansia 
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muciniphilia compared to controls. In addition, via 16s rRNA sequencing of cecum mucosa, 
Bifidobacterium, Lactobacillus, Allobaculum, and other genera were found to be negatively 
correlated with body fat percentage and inguinal fat weight. Allobaculum in particular was 
increased in both the LF and 3% grapes groups.  Notably, grape feeding attenuated the high-fat 
induced impairment in localization of the intestinal tight junction protein zonula occludens. 
Collectively, these data indicate that some of the adverse health consequences of consuming a 
diet rich in saturated fat can be attenuated by table grape consumption. 
 
Introduction  
     Currently 35.9% of adults and 17% of youth in the United States have been diagnosed as 
obese [1]. Obesity is also a global health condition affecting more than 10% of adults worldwide 
[2]. Of growing concern is the association between the rise in obesity and chronic inflammatory 
conditions such as type 2 diabetes, hypertension, and cardiovascular disease [3].  Physiologically, 
obesity is the result of an expansion of white adipose tissue (WAT) which typically elicits 
inflammatory signals involved in the recruitment of macrophages and other immune cells into the 
WAT. This results in a proliferation of circulating and tissue levels of proinflammatory cytokines 
and chemokines [4]. While increased tissue levels of these proinflammatory agents perpetuates 
the inflammatory cycle, those released systemically impair glucose disposal and lipid metabolism 
and hemostasis that contribute to the development of metabolic diseases. However, the exact 
mechanisms which initiate WAT inflammation resulting from diet-induced obesity remain 
unclear.     
     Gut microbes have received much attention due to their potential involvement in the 
development of obesity [5], chronic inflammation [6-8], and insulin resistance [9]. Diets high in 
fat, particularly those rich in saturated fatty acids  found in milk fat [10], have been implicated in 
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the reduction of gut barrier-protecting bacteria as well as increasing the abundance of deleterious 
bacteria including sulfidogenic bacteria [reviewed in 11]. A correlation exists between the extent 
of these changes in microbiota and the degree of obesity and insulin resistance in test subjects 
[12]. Furthermore, the main byproduct of sulfidogenic bacteria like Bilophila wadsworthia and 
Desulfovibrionaceae spp. is hydrogen sulfide gas, which is genotoxic and cytotoxic and 
positively correlated with development of ulcerative colitis, gut inflammation, irritable bowel 
syndrome, and colon cancer [10, 13, 14].   
     In contrast, changes to the intestinal microbiome can have beneficial effects. Indeed, research 
models have demonstrated that elimination of gut microbes [5-9, 11, 12, 15] or inoculation with 
specific pre- (e.g., non-digestible sugars, fiber, or polyphenols) or probiotics (e.g., Lactobacillus 
acidophilus, Bifidobacterium spp., Akkermansia muciniphila, Clostridium trybutyricum) 
[reviewed in 11, 16-19] can attenuate obesity or metabolic dysfunction. Polyphenols found in 
fruits and vegetables [20-22] are of particular interest as they are poorly absorbed in the upper 
gastrointestinal tract, and thus persist in the distal small intestine, cecum, and colon [23] where 
they may influence microbiota taxa and their metabolites [24]. In addition, their anti-
inflammatory, anti-oxidant, or anti-microbial actions have been reported to positively influence 
gut microbes and inflammation [reviewed in 25].  
     Grapes are rich in polyphenols including anthocyanins [reviewed in 25], and thus may have 
beneficial effects on intestinal or systemic inflammation. The anti-inflammatory and anti-oxidant 
properties of California table grapes have been demonstrated in rats supplemented with 9 human 
servings (3%, w/w) of powdered table grapes for 18 weeks, resulting in lowered blood pressure, 
improved cardiac function, and reduced systemic inflammation and oxidative damage [26]. These 
effects correlated with increased cardiac peroxisome proliferator-activated receptor (PPAR)α/γ 
activity and decreased nuclear factor kappa B (NF-κB) activity, along with reductions in cytokine 
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levels [27]. Similarly, table grape-mediated reductions in atherosclerotic lesion areas were 
associated with increased serum antioxidant status and decreased macrophage-mediated oxidation 
of low density lipoproteins (LDL) [28]. Additionally, when women supplemented with powdered 
California table grapes (36 g/d) their plasma lipid profile improved and plasma (e.g., tumor 
necrosis factor alpha, TNFα) or urine (e.g., prostaglandin F2 alpha) markers of inflammation and 
oxidative stress were reduced [29]. Consistent with these data, we demonstrated that C57BL/6J 
mice fed a high fat diet (60% kcals from lard) supplemented with powdered California table 
grapes (3%, w/w), improved glucose tolerance at 5 weeks, and decreased markers of 
inflammation ≈20-50% in serum and WAT at 18 weeks without affecting body fat levels or food 
intake [30].  
     Collectively, these data indicate that; (i) gut microbiota are influenced by diets abundant in 
saturated fats such as butter fat, in a manner that impacts gut inflammation and barrier function, 
and systemic inflammation, (ii) non-digestible carbohydrates and polyphenols positively impact 
adverse outcomes caused by high fat-feeding, and (iii) grape consumption can attenuate 
inflammation and oxidative stress in several animal models and in humans. However, little is 
known about how California table grapes decrease chronic inflammation associated with 
saturated fat-feeding and obesity. Therefore, the objective of this study was to examine the extent 
to which consuming California table grapes reduces adiposity, hepatic steatosis, markers of 
inflammation or lipid metabolism, or impacts gut microbiota in mice fed a butter-rich diet. 
Materials and Methods  
Animal 
     Four-week old, male C57BL/6J mice were obtained from Jackson Laboratories (Bar Harbor, 
ME, USA) and acclimated on a standard chow diet for 1 week. Mice were housed in pairs, 
maintained at a temperature of 22
◦
C with 50% humidity, and exposed to a 12 h light/ 12 h dark 
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cycle. Mice received food and water ad libitum and measures of body weight and food intake 
were conducted once and twice per week, respectively. All experimental procedures were 
performed under ethical standards and approved by the Institutional Animal Care and Use 
Committee of the University of North Carolina at Greensboro. 
 
Diets 
     Animals were randomly assigned to one of five dietary treatments (n=10 per treatment group) 
as follows: low fat (LF; 10% of energy from  fat), high fat (HF; 34% of energy from fat) plus 3% 
powdered grapes (w/w; HF-3G), high fat plus 3% sugar (w/w; HF-3S), high fat plus 5% 
powdered grapes (HF-5G) and high fat plus 5% sugar (HF-5S). The high fat diets consisted of 
approximately 3% energy from soybean oil and 31% energy from butter. Thus, the HF diets were 
rich in fat, especially saturated fat, and mimicked the average calories from fat in an American-
type diet. The lyophilized (i.e., powdered) California table grapes, kindly provided by the 
California Table Grape Commission consisted of a mixture of red, green, and purple seeded and 
seedless grapes.  The 3% and 5% dietary levels of grapes were comparable to 9 and 15 human 
servings (1 serving is equivalent to 1 cup of whole berries) of grapes, respectively. The HF-3S 
and HF-5S diets consisted of a mixture of fructose and glucose to control for the natural sugar 
content of the powdered grape diets. Detailed composition of the diets is illustrated in Table 3.1.  
 
Intraperitoneal glucose tolerance tests (GTT) and fasting insulin levels  
     Intraperitoneal (i.p.) GTT were performed on weeks 3, 6, and 9 on non-anesthetized mice. 
Mice were fasted for 8 h and given an i.p. injection of glucose (i.e., 20% solution at 1 g/kg body 
weight). Blood from the tail vein collected at baseline and 5, 15, 30, 60, and 120 minutes post-i.p. 
glucose injection was used to quantify glucose levels using a Bayer Contour blood glucose 
monitor and strips (Bayer Healthcare, Tarrytown, NY, USA). Plasma insulin levels were detected 
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using an ultrasensitive mouse insulin kit (Crystal Chem, Inc, Downers Grove, IL). The 
homeostasis model assessment method (HOMA) for insulin resistance (IR) was used employing 
the following formula: [fasting insulin concentration (ng/ml) x 24 x fasting glucose concentration 
(mg/dl)] / 405 [16]. 
 
 Body fat measurements via Dual X-Ray Absorptiometry (DEXA) 
     Percent body fat was measured using DEXA on a GE Lunar Prodigy Advanced System (GE 
Healthcare, Milwaukee, WI) at weeks 5 and 10. During the measurement, mice were lightly 
anesthetized with isoflurane using a SomnoSuite Small Animal Anesthesia System with 
Integrated Digital Vaporizer isoflurane system. Measurements were taken in duplicate to reduce 
the possibility of error and values expressed are an average of the two measurements.  
 
Tissue collection 
     After 11 weeks of dietary intervention, mice were fasted for 8 h and euthanized via isoflurane-
induced anesthesia followed by decapitation. Plasma was collected at time of harvest. Four white 
adipose tissue (WAT) depots were collected; epididymal, mesenteric, inguinal, and 
retroperitoneal. Additionally, livers were harvested and intestinal mucosa and digesta were 
collected from the duodenum, jejunum, ileum, cecum, and proximal and distal colon. Weights of 
the WAT depots and liver were recorded and all collected samples were immediately snap-frozen 
in liquid nitrogen and stored at -80
o
C until analysis.  
 
Liver and serum triglyceride (TG) levels 
     Liver TG content was measured as previously described [31]. Plasma TG content was 
determined using a commercial assay from Thermo Scientific and was conducted following the 
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manufacturer’s protocol (Infinity TG assay #TR22421 and TG standards #TG22923; Norcross, 
GA). 
 
RNA extraction and qPCR 
     Adipose and intestinal samples were homogenized in QIAsol reagent and total RNA was 
extracted using QIAgen mini lipid kit obtained from Qiagen (Valencia, CA). For hepatic samples, 
a QIAgen mini universal kit from Qiagen was used. The quality and concentration of RNA were 
examined using absorbance at 260 nm and integrity determined using the absorbance ratio of 
260/280 on a Nanodrop ND-1000 Spectrophotometer (Thermo Scientific, Wilmington, DE). 
Complementary DNA was created by reverse transcription using 1 ug of RNA and a high 
capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA) according to manufacturer’s 
protocols. qPCR was performed in a 7500 FAST Real Time PCR system (Applied Biosystems). 
The expression of different genes related to inflammation, lipogenesis, and lipolysis in WAT 
depots and liver were measured using Taqman Gene expression assays purchased from Applied 
Biosystems. TATA-binding protein (Tbp) was the endogenous reference gene utilized for all 
assays and fold differences in gene expression were calculated as 2
−ΔΔCt
. 
 
Immunoblotting 
     Immunoblotting was conducted as previously described [31] using primary antibodies for 
sterol-CoA desaturase-1 (#2283S; SCD1, Cell Signaling), carnitine palmitoyltransferase 1A 
(#12252S; CPT1a, Cell Signaling), peroxisome proliferator-activated receptor gamma (#2443S; 
PPARγ Cell Signaling), β-actin (#4967; Cell Signaling), proliferator-activated receptor alpha 
(#sc9000; PPARα, Santa Cruz Biotechnology Inc., Santa Cruz, CA), glycerol-3-phosphate 
acyltransferase (#sc382257; GPAM, Santa Cruz), and sterol regulatory element-binding protein 
1C (#sc366; SREBP1c, Santa Cruz) all at dilutions of 1:1000. Adipocyte fatty acid binding 
47 
 
protein (aP2) was kindly provided by Dr. David Bernlohr (U. of Minnesota) and used at a 
1:10,000 dilution. Horseradish peroxidase-conjugated secondary antibodies were probed for 2 h 
at room temperate at 1:1000 dilutions. Blots were exposed to a chemiluminescence reagent and 
X-ray films were developed using a SRX-101A Konica Minolta film developer.    
 
Barrier function in ileum 
     The localization of the tight junction protein zonula occludens-1 (ZO-1) was determined in 
ileum samples that had been embedded in Tissue-Tek Cyro-OCT compound, sliced in 5 mm 
sections, fixed in cold methanol, and incubated with a polyclonal rabbit anti-ZO-1 antibody as 
previously described [32]. 
 
 PCR amplification of 16S rRNA and functional gene targets  
     Real-time quantitative PCR (qPCR) was performed with a 7900HT Fast Real-Time PCR 
System (Applied Biosystems, Foster City, CA). 16S rRNA gene-specific primers were used to 
target specific bacterial genera; Akkermansia muciniphila, Bilophila  wadsworthia (F-
AAGTCCTTCGGGGCGAGTAA) (R-ATCCTCTCAGACCGGCTAC), Desulfovibrio spp. 
(DSV), Desulfobulbus spp. (DBB), Desulfobacter spp. (DSB), and Desulfotomaculum spp. 
(DFM) [4]. The B. wadsworthia-specific dissimilatory sulfite reductase (dsrA-Bw) [20], which 
encodes an enzyme that catalyzes a step in the reduction of inorganic sulfate to hydrogen sulfide, 
was targeted to measure the abundance of this member of the Desulfovibrionaceae family.   Four 
functional genes utilized by Fusobacterium nucleatum in the fermentation of cysteine were 
measured; i.e., two homologues of L-cysteine desulfhydrase (FN0625 and FN1220), 
Cystathionine-β synthase (FN1055), and L-methionine-γ-lyase (FN1419). The abundance of 
butyrate-producing bacteria was also measured using the degenerate primer Butyrl-CoA 
transferase.  Standard curves were constructed using cloned 16S rRNA and functional genes or 
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amplified PCR product. Genomic DNA extraction and PCR experiments were conducted as 
previously described [4]. 
 
 Sequencing of 16s rRNA gene using Illumina Mi-Seq platform  
     To assess bacterial community structure, primers specific for 16S rRNA V4-V5 region 
(Forward: 338F: 5’-GTGCCAGCMGCCGCGGTAA-3’ and Reverse: 806R: 5’- 
GGACTACHVGGGTWTCTAAT-3’) that contained Illumina 3' adapter sequences as well as a 
12-bp barcode were used. Sequences were generated by an Illumina MiSeq DNA platform at 
Argonne National Laboratory and analyzed by the program Quantitative Insights Into Microbial 
Ecology (QIIME) [33]. Operational Taxonomic Units (OTUs) were picked at 97% sequence 
identity using open reference OTU picking against the Greengenes database (05/13 release)
 
[34]. 
OTUs were quality filtered based on default parameters set in the open-reference OTU command 
in QIIME and sequences were rarified to an equal sampling depth of 15000 reads per sample. 
Representative sequences were aligned via PyNAST
 
[33], taxonomy assigned using the RDP 
Classifier
 
[35], and a phylogenetic tree was built using FastTree
 
[36]. Beta Diversity is 
represented by measuring UniFrac distances calculated using both weighted and unweighted 
algorithms and visualized with PCoA plots generated in Emperor. Prior to statistical analyses, 
OTUs occurring in less than 50% of samples were filtered from the OTU table. Significant 
changes in OTU abundance were assessed using Kruskal Wallis test (FDR correction p ≤ 0.05). 
Multivariate statistical tests include ADONIS, ANOSIM, and PERMANOVA tests [33]. 
Spearman correlations and Principal Component Analysis (PCR) were run using MATLAB 
software.  
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Statistical Analysis 
     Data were analyzed using a one-way ANOVA and Student’s t test to compute individual 
pairwise comparisons of means (p<0.05). We also used Bonferroni’s posthoc test to perform 
specific comparisons where appropriate. Analyses were conducted using the JMP software 
program version 10.0 for Windows (SAS, Cary, NC).  Relative abundances generated from 16s 
rRNA sequencing were analyzed in GraphPad Prism Version 6 using ANOVA followed by 
Dunn’s test for multiple comparisons. Data are expressed as means + S.E.M.  
 
Results 
Grape consumption decreases body fat  
     Body weight gains and energy intakes were greater in all HF-fed mice compared to the LF 
control mice (Table 3.2). Mice fed powdered grapes (HF-3G, HF-5G) had similar body weights 
and energy intakes compared to their HF-sugar controls (HF-3S, HF-5S; Table 3.2). Mice fed the 
HF-sugar control diets had greater body fat percentage and total WAT depot weights compared to 
the LF controls (Fig. 3.1). Mice fed the HF-3G diet had lower percent body fat at week 5 and 
mice fed powdered grapes at both levels had lower body fat percentages and inguinal fat depot 
weights at week 10 compared to their respective HF-sugar controls (Fig. 3.1). The HF-3G diet 
had lower total WAT depot weights compared to HF-3S controls (Fig. 3.1).   
GTT, fasting glucose, insulin, and TG levels, and HOMA-IR scores unaffected by grapes 
     To assess the impact of grape consumption on insulin resistance and glucose sensitivity, GTT 
were conducted at weeks 3, 6, and 10, and fasting plasma glucose and insulin and HOMA-IR 
were measured at week 11. Mice consuming the HF-sugar control diets had impaired GTT at all 
three time points compared to the LF controls (Fig. 3.2). However, consuming grapes did not 
significantly improve GTT, fasting insulin, glucose, serum TG levels, or HOMA-IR scores. 
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Grape consumption lowers hepatic TG levels and the expression of several lipogenic genes  
     Liver tissue was analyzed to assess the impact of grape consumption on liver TG levels and 
markers of lipogenesis and fatty acid oxidation. Mice consuming the HF-sugar control diets had 
greater liver weights, TG levels (HF-5S only), and mRNA levels of the lipogenic genes Pparγ2, 
Scd1 (HF-5S only), Srebp1c, cluster of differentiation 36 (Cd36; HF-5S only), and glycerol-3-
phosphate acyltransferase 2 (Gpat2; HF-3S only) compared to the LF-fed mice (Fig. 3.3). Mice 
fed the HF-3G diet had decreased mRNA levels of Pparγ2, Scd1, fatty acid binding protein 4 
(Fabp4), and Gpat1 compared to the HF-3S controls. Mice fed the HF-5G diet had decreased TG 
levels and mRNA levels of Gpat1 compared to the HF-5S controls. None of the genes associated 
with fatty acid oxidation (e.g., Pparα, Cpt1a, acyl-CoA oxidase 1 (Acox1)) were impacted by 
grape feeding. Consuming grapes had no impact on the protein levels of Pparγ, Scd1, Pparα, 
Fabp, Cpt1a, or Gpam (data not shown). 
 
Grape consumption differentially impacts WAT genes associated with inflammation and lipid 
metabolism 
     To determine whether insulin resistance caused by HF-feeding was due to WAT inflammation, 
inguinal (subcutaneous), epididymal (visceral), and mesenteric (visceral) WAT mRNA levels for 
several proinflammatory genes (i.e., cluster of differentiation 11c (Cd11c), epidermal growth 
factor-like module containing mucin-like hormone receptor 1 (Erm1; F4/80 human orthologue), 
monocyte chemoattractant protein 1 (Mcp1),  Tnfα, Toll-like receptor 4 (Tlr4), and interleukin 6 
(Il6) were measured. In epididymal WAT, mice fed the HF-sugar controls had increased mRNA 
levels of Tnfα (HF-5S), Cd11c (HF-5S), Il6, and Mcp1 (HF-5S) compared to the LF controls (Fig. 
3.4A). Grape feeding had no impact on these genes.  In inguinal depot WAT, only mice fed the 
HF-5S diet had increased inflammatory gene expression (i.e., Mcp1), which was decreased in 
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mice fed the HF-5G diet (Fig. 3.4A). In mesenteric WAT, inflammatory gene expression was not 
increased by HF-feeding. 
     To determine if the reduction in adiposity by grape consumption was due to alterations in the 
expression of genes associated with fat synthesis or oxidation, epididymal and inguinal WAT 
were analyzed for mRNA markers of; (i) lipogenesis (i.e., Pparγ2, Srebp1c, Scd1, acylglycerol-3-
phosphate-O-acyltransferase 2 (Agpat2), fatty acid synthase (Fas), acetyl-CoA carboxylase (Acc), 
perilipin 1 (Plin1), Gpat1), (ii) lipolysis (i.e., adipose TG lipase (Atgl); and (iii) beta-oxidation 
(i.e., Acox1, Cpt1b, Pparα). In epididymal WAT, the mRNA levels of the lipogenic genes 
Pparγ2, Agpat2, and Scd1 (HF-5S) were higher in the HF-sugar controls compared to the LF-
controls, and similar to the HF-grape groups (Fig. 3.4B).  In inguinal WAT, the mRNA levels of 
the lipogenic genes Srebp1c (HF-3S), Scd1, Agpat2 (HF-5S), Fas (HF-5S), and Gpat2 (HF-5S) 
were higher in the HF-sugar controls compared to the LF-controls (Fig. 3.4C). Mice fed the HF-
5G diets had lower mRNA levels of Agpat2 compared to HF-5S control.  The mRNA levels of 
the fatty-acid oxidizing genes Pparα and Cpt1b, and the lipolytic gene Atgl (HF-3S) were lower 
in the HF-sugar controls compared to the LF control, and similar to the HF-grape groups. 
 
Minimal influence of HF-feeding and grape consumption on markers of intestinal inflammation 
and barrier function 
     Given the reported adverse effects of consuming saturated fats [reviewed in 11], particularly 
from milk fat [10], on intestinal health, and potential prebiotic impact of grapes, we measured the 
effects of our diets on markers of intestinal inflammation and barrier function. For inflammatory 
status, the mRNA levels of Cd11c, Erm1, Mcp1, Tnfα, Tlr4, and Il6 in ileum and distal colon 
mucosa and the activity of duodenal alkaline phosphatase and ileal myeloperoxidase were 
measured. Surprisingly, the only proinflammatory gene increased in the ileal mucosa of HF-sugar 
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fed mice was Tnfα, which was similar to the HF-5G group (Fig. 3.5A). None of the 
proinflammatory genes measured in the colonic mucosa where increased by HF-sugar feeding or 
grape consumption. Similarly, the activities of alkaline phosphatase and myeloperoxidase were 
not influenced by HF-sugar feeding or grape consumption (data not shown).   
     To assess intestinal barrier function, the mRNA levels of the tight junction proteins zonula 
occludens (Zo1), claudin-1, and occludin-1 and the localization of ZO-1 at the apical surface of 
the ileal epithelium were measured. Although the ileum mucosal gene expression of these tight 
junction proteins was not impacted by the diets, the localization of ZO-1 was impaired in the HF-
sugar control diets compared to the LF controls, and improved by grape feeding (Fig. 3.5B).  
 
16s rRNA sequencing of the gut microbiota reveals genera associated with body fat percentage 
and inguinal fat pad weight  
     Given the reported adverse effects of consuming saturated fats [reviewed in 11], particularly 
from milk fat [10], on intestinal microbes, we measured the effects of our diets on the abundance 
of several mucosal sulfidogenic bacteria (i.e., DBB, DSB, dsrA, DFM, DSV, and B. wadsworthia) 
or their gene products (i.e., B. wadsworthia specific dsrA-Bw, Fusobacterium nucleatum 
functional genes including two L-cysteine desulfyhdrases (FN0625 and FN1220) cystathionine-β 
synthase (FN1055), and L-methionine-γ-lyase (FN1419)). Although HF-feeding did not increase 
the expression of any of these genes associated with sulfur metabolism in ileum or colon mucosa 
compared to LF control mice (data not shown), mice consuming the HF-3G diet had decreased 
mRNA levels of DSB and dsrA-Bw expression in ileum mucosa compared to mice consuming the 
HF-3S diet (Fig. 3.6A).  
     We also measured the expression of a functional gene (i.e., butyrl-CoA transferase) of health- 
promoting, butyrate-producing bacteria and on the abundance of Akkermansia muciniphila, a 
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mucin-degrading bacteria associated with prebiotic-mediated reduction in obesity [37]. Although 
not statistically significant, mice consuming grapes had increased levels of Akkermansia 
muciniphila in the cecum digesta (HF-3G), colon digesta (HF-3G), and proximal colon mucosa 
(HF-5G) compared to their HF-sugar controls (Fig. 3.6B). 
 
Sequencing of the 16s rRNA gene reveals alterations in microbial structure and relationships    
     In order to better understand the impact of grape feeding on gut bacterial community structure, 
an untargeted approach was used by sequencing the 16s rRNA gene in cecum mucosal samples. 
Sequencing was performed on an Illumina MiSeq platform using primers targeting the V4-V5 
region of the 16s rRNA gene. Data were analyzed using QIIME 1.8 Software (33-Caporaso et al. 
2010). Alpha Diversity analyses revealed that the HF groups containing 5% grapes or 5% sugar 
resulted in reduced observed species compared to 3% grapes (p = 0.0002) or 3% sugar (p< 
0.0001), respectively (Fig 3.7). Notably, HF diet containing 3% sugar reduced observed species 
compared to 3% grapes (p=0.0026), but there was no difference in observed species in 5% grape 
and sugar groups. These results suggest that elevated sugar content may result in decreased alpha 
diversity or membership of the gut microbiota.  Principal Coordinate Analysis (PCoA) of 
weighted UniFrac distances did not reveal obvious differences in beta diversity or community 
structure across diet groups but there was clear separation between the LF group and HF groups 
based on unweighted UniFrac distances (Fig. 3.8). To further interrogate differences between diet 
groups, multivariate statistical tests including ADONIS, ANOSIM, and PERMANOVA were 
conducted. Significant differences were found among both unweighted and weighted UniFrac 
distances across diet groups (Table 3.3). Subsequently, OTUs that were not represented in up to 
50% of the samples were removed to reduce noise from low abundance OTUs. Next, a Kruskal 
Wallis test was performed to determine significant differences in relative abundance of taxa 
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between groups. Here, it was found that several bacterial taxa were significantly altered based on 
diet (Fig. 3.9). While many genera were reduced in the HF diets compared to the LF diet, some 
were selectively increased in HF-3G group such as Ruminoccocus and Anaeroplasma in the 
Firmicutes and Tenericutes phylum, respectively (Fig. 3.9).  
     To assess differences between specific diet groups, Principal Component Analysis (PCA) was 
conducted and clear clustering was evident between the LF and HF-3G group (Fig. 3.10A) and 
between the HF-3G and HF-3S group (Fig 3.10B). Principal Component Analysis between the 
LF and HF-3G group revealed that ~60% of the variance in relative bacterial abundance between 
the two groups is explained with Principal Component 1 (PC1).  PC1 exhibits strong correlations 
with two strains of bacteria: S24-7 within the Bacteroides phylum and Clostridiales in the 
Firmicutes phylum (Fig. 3.10A).  This indicates that the variance explained by PC1 is primarily 
due to the relative abundances of these two bacterial strains.  Principal component 2 (PC2) 
explained an additional 20% of the variance between groups and was primarily correlated with 
Akkermansia.  PCA between the HF-3G and HF-3S groups revealed that ~60% of the variance in 
relative microbial abundance between the two groups was explained by PC1.  PC1 was once 
again strongly correlated with S24-7 and Clostridiales (Fig. 3.10B).  PC2 explained ~20% of the 
variance and exhibited a strong correlation with Akkermansia, however this was positively 
associated with the HF-3S group. These data suggest that most variance between the LF and HF-
3G was explained by the abundance of S24-7 in the LF group. Interestingly, S24-7 also explained 
the variance between the HF-3G and HF-3S groups, as it was positively correlated with HF-3G 
compared to HF-3S. These data may suggest that S24-7 is associated with improved metabolic 
profile of the LF and HF-3G groups. 
     Lastly, Spearman Correlation analysis revealed significant negative correlations between body 
fat percentage and several genera (Fig. 3.11, Table 3.4) with the most profound being 
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Bifidobacterium (p = 0.0001), a butyrate producer, and others including Lactobacillus (p = 
0.0221) and Allobaculum (p = 0.034; Fig 3.11, Table 3.4). These particular genera were similarly 
correlated with inguinal fat pad weight. Clostridiales of the Firmicutes phylum was positively 
correlated with body fat percentage (p = 0.0065). Interestingly, a heatmap made from the taxa that 
were significantly correlated with body fat percentage, reveals that Allobaculum belonging to the 
Tenericutes phylum was increased in both the LF and HF3G group (Fig. 3.11). Little is known 
regarding the functional role of Allobaculum in the gut ecosystem and is currently being 
investigated for its potential association with a lean phenotype and improved metabolic health.  
 
Discussion 
     Our data demonstrate that consuming table grapes (i.e., 3-5%, w/w; equivalent to 9-15 human 
servings) attenuates the accumulation of body and liver fat in mice fed a diet rich in butter 
compared to control mice. However, these lipid-lowering effects of grapes were not associated 
with improvements in glucose tolerance or markers of inflammation in intestinal mucosa or 
WAT. Notably, the impaired localization of the intestinal tight junction protein ZO-1 in high fat-
fed mice was improved by grape consumption. Populations of the deleterious sulfidogenic 
bacteria Desulfobacter spp, and the Bilophila wadsworthia-specific dissimilatory sulfite reductase 
gene were decreased by grape consumption (HF-3G), and populations of the beneficial bacterium 
Akkermansia muciniphila tended to be higher the colonic mucosa (HF-5G) or digesta (HF-3G) of 
grape fed mice compared to their respective controls. Additionally, via 16s rRNA sequencing 
analysis, we found significant differences across groups in the relative abundance of S24-7 and 
Akkermansia which were found to be negatively correlated with HF diet compared to the LF diet. 
Intriguingly, correlation analysis showed a strong negative correlation between Bifidobacterium 
and body fat percentage and inguinal fat pad weight. Taken together, these data indicate that 
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consumption of table grapes attenuates adiposity and steatosis that are positively correlated with a 
marker of intestinal integrity and changes in several species of gut microbes in mice fed a butter-
rich diet.   
 
Influence of dietary polyphenols on adiposity, steatosis, and glucose tolerance 
     Many studies have demonstrated that consuming diets rich in calories from fat, particularly 
saturated fat, and sugars promote obesity and its metabolic complications [reviewed in 11].  The 
ability for foods rich in polyphenols, including grapes, to prevent obesity-mediated inflammation 
or related disorders has been demonstrated [reviewed in 25]. For example, grape seed procyanidin 
extract supplementation reduces body weight gain and adipose tissue mass in hamsters fed a HF 
diet [38].  Additionally, mice fed a HF diet supplemented with muscadine grape phytochemicals 
rich in anthocyanins had decreased body weights, less lipid accumulation in the liver, and 
improved glucose tolerance compared to high fat controls [39]. 
     While several studies demonstrate anti-inflammatory and anti-obesity effects of grapes or their 
extracts, the mechanisms by which these effects occur are less clear.  Anthocyanins are one of the 
most abundant phytochemicals in grapes [31] and therefore may be responsible for mediating the 
reductions in adiposity and steatosis. For example, anthocyanins purified from purple sweet 
potatoes attenuated hepatic lipid accumulation via the activation of adenosine monophosphate-
activated protein kinase and decreased expression of SREBP1 and its downstream target genes  in 
mice fed a HF diet [40].  Our study found that powdered grape supplementation at 3% and 5% 
reduced body weight and fat gain and hepatic lipid accumulation, but  had no significant effects 
on the expression of Srebp1c and Fas.  One explanation for the differential effects of extracted 
anthocyanins cited above [40] and our anthocyanin-rich grapes may be due to the binding of 
anthocyanins to fibers or proteins in the intact grapes, making them less bioavailable to the host. 
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Although we discovered that the expression of several hepatic genes associated with lipogenesis 
(e.g., Pparγ, Scd1, Fabp4, Gpat1) in liver were lower in mice consuming the HF-3G compared to 
the HF-3S controls,  the protein levels of associated with these genes were not lowered by grape 
feeding. However, we did not measure the activity of these proteins, and therefore do not know 
they were impacted by grape consumption. 
 
Relationship between dietary fat, sulfite-reducing bacteria, barrier function, and inflammation 
     Devkota et al. [10] demonstrated that feeding a milk-fat-based diet similar in amount and 
composition to the western diet (i.e., 37% kcals from fat) to IL-10 knockout mice decreased gut 
barrier-protecting bacteria and increased sulfate-reducing bacteria and increased intestinal 
markers of inflammation consistent with inflammatory bowel disease [10]. Mice consuming the 
milk fat diet had increased abundance of B. wadsworthia, which was associated with a pro-
inflammatory T helper type immune response and increased colitis. Notably, taurine-conjugated 
bile salts caused these inflammatory responses, in part, due to their high sulfur content, which 
stimulates sulfite-reducing bacteria like B. wadsworthia. In a parallel 3 week study, these authors 
fed C57BL/6J mice the same high fat diet [10]. Consistent with the IL-10 knockout mice, 
C57BL/6J mice fed the milk fat diet had an increased bloom of the sulfidogenic bacteria B. 
wadsworthia and the B. wadsworthia-specific dissimilatory sulfite reductase gene dsrA-Bw. Milk 
fat-fed C57/6J mice also had a higher abundance of Bacteriodetes and a lower abundance of 
Firmicutes compared to the low fat-fed mice [10]. However, milk fat-fed C57BL/6J mice did not 
present overt colitis as did the IL-10 knockout mice [10]. In the present study, we did not observe 
any increases in the expression of sulfidogenic bacteria-related genes in the high fat-fed controls 
compared to the LF fed mice, although the HF-3G had lower expression levels of dsrA-Bw and 
DSB in the ileum mucosa compared to the HF-3S control group (Fig. 3.6A). This decreased 
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abundance of sulfidogenic bacteria correlated with improved localization of the ileal tight 
junction protein ZO-1 (Fig. 3.5). Although no markers of inflammation in the intestinal samples 
were significantly increased by the milk fat based diet or decreased by grape feeding, the 
expression levels of several inflammatory genes in visceral epididymal WAT (i.e., Tnfα, Cd11c, 
Mcp1) and subcutaneous inguinal WAT (i.e., Mcp1) were increased by HF feeding (Fig. 3.4A), 
and HF-5G consumption reduced Mcp1expression in inguinal WAT compared to its control HF-
5S (Fig. 3.4A).   
      These results are comparable to data showing that HF feeding selectively increases the 
abundance of a specific type of bacteria that are associated with intestinal inflammation [41]. 
Apoa-I knockout mice, which present impaired glucose tolerance and increased adiposity, and 
wild type mice were fed a very HF diet (i.e., ~60% kcals from lard) for 25 weeks. HF fed mice 
had increased abundance of Desulfovibrionaceae, a family of sulfate/sulfite reducing bacteria that 
produce hydrogen sulfide, a genotoxic gas that causes barrier dysfunction and endotoxemia [42].  
Consistent with these data, we showed that C57BL/6J mice fed a very HF diet (i.e., ~60% kcals 
from lard) for 20 weeks increased three types of sulfidogenic bacteria in colonic mucosa, 
impaired localization of ZO-1, and mRNA levels of markers of macrophage infiltration in 
intestinal mucosa and WAT compared to LF fed mice [32]. Collectively, these data demonstrate 
that consuming diets enriched with lard or butter, two fat sources containing high levels of 
saturated fatty acids, increases the abundance or markers of sulfate-reducing bacteria associated 
with impairment of intestinal barrier function and contribute to systemic inflammation. 
 
Relationship between dietary fat, Akkermansia muciniphila, barrier function, and inflammation 
     Akkermansia muciniphila, a commensal, mucin-degrading bacteria, plays a role in preventing 
the development of diet-induced obesity [37]. Under normal conditions, these bacteria represent 
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3-5% of the gut microbial population in humans. However, HF feeding reduces the colonic 
abundance of these bacteria in mice 100-fold, and oligofructose prebiotic treatment prevents this 
loss. Oligofructose-mediated increase in A. muciniphila was linked to decreased metabolic 
endotoxemia and markers of inflammation in WAT. Furthermore, supplementation of C57BL/6J 
mice fed a HF diet with A. muciniphila for 4 weeks lead to a decrease in adiposity, gut barrier 
dysfunction, metabolic endotoxemia, glucose intolerance, insulin resistance, and Cd11c 
expression in WAT, and improved mucus thickness along the epithelium compared to control 
mice [37]. Consistent with these data demonstrating that oligofructose prebiotic treatment 
attenuates a HF diet-induced reduction of A. muciniphila, our data indicate that supplementing 
high fat, butter-rich diets with 5% California table grapes increases the abundance of A. 
muciniphila in proximal colon mucosa compared to the HF-sugar controls (Fig. 3.6B). This 
increase in A. muciniphila was positively associated with improved localization of ZO-1 in the 
apical area of the ileal epithelium compared to HF control mice (Fig. 3.5). Furthermore, based on 
our 16s rRNA sequencing data of the cecum mucosa, the genus Akkermansia was positively 
associated with mice fed a LF diet, further supporting a relationship with a lean phenotype.  
 
Limitations and unanswered questions 
     The current study did not achieve the anticipated increases in intestinal and systemic 
inflammation in young C57Bl/6J mice fed a high fat diet rich in milk-fat as demonstrated in IL-10 
knockout mice fed milk-fat [10] or in Apoa-I knockout mice fed lard [40].  Perhaps feeding mice 
extremely HF diets (e.g., 60% kcals from lard) is necessary to instigate intestinal and systemic 
inflammation [11, 30]. Our current study sought to provide a more physiological approach to 
achieve diet-induced obesity accompanied by systemic and intestinal inflammation. The use of 
this more physiological model for the time span of 11 weeks may not have been aggressive 
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enough in this model to elicit a robust inflammatory response, as the percentage of calories from 
fat (34% of kcals) or the composition of fat (primarily milk fat) may not have been adequate, to 
induce a severe case of obesity and inflammation. Future studies should examine the effect of 
different polyphenols or fractions present in grapes on obesity and systemic and intestinal 
inflammation using a diet induced obesity mouse model fed a diet that is more representative of 
the fat composition of the typical American diet (i.e., a mixture of animal and vegetable fats 
consisting of beef tallow, lard, milk fat, shortening, and vegetable oils [43].)  
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Table 3.1. Diet Formulations 
 
LF, low fat control; HF-3S, high fat- 3% sugar control; HF-3G, high fat- 3% grapes; HF-5S, high 
fat-5% sugar control; HF-3G, high fat-5% grapes 
 
 
 
 
 
 
 
62 
 
Table 3.2. The Effect of Diet Composition on Weight Gain, Consumption, and Utilization 
 
Mean ± SEM without a common lower case letter in a column differ (p<0.050 using one-way 
ANOVA and Student’s t test.  BWG = total body weight gain (g). FI= total food intake per cage 
(g). FCE= food conversion efficiency per cage. Kcal= total caloric intake per cage (kcals).   
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Table 3.3. Statistical Analyses of Unifrac Distances 
 
 
  
64 
 
Table 3.4. Taxa Associated with Body Fat 
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Figure 3.1. Diet Induced Changes to Fat Mass. Adiposity indices of C57BL/6J mice fed a low 
fat diet or butter-rich, high fat diets with or without 3% or 5% powdered grapes for 10 weeks.  
(A) Body fat percentages were measured at week 5 and week 10 using dual energy x-ray 
absorptiometry (DEXA).  (B) At week 11, epididymal, inguinal, retroperitoneal, and mesenteric 
white adipose tissue (WAT) depots were excised and weighed. The weights of the epididymal, 
inguinal, retroperitoneal, and mesenteric depots were measured, and their sum labelled total 
WAT.  Means ± SEM without a common lowercase letter differ (p<0.05) using one-way ANOVA 
and Student’s t test.  Means ± SEM (n=9-10) sharing the symbol “*” differ using the Bonferroni’s 
adjustment (p<0.01).; LF, low fat; 3S, high fat diet containing 3% sugar; 3G high fat diet 
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containing 3% grapes; 5S, high fat diet containing 5% sugar; 5G, high fat diet containing 5% 
grapes. 
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Figure 3.2. Glucose Tolerance Tests. Glucose tolerance tests (GTT) s of C57BL/6J mice fed a 
low fat diet or butter-rich, high fat diets with or without 3% or 5% powdered grapes for 10 weeks.  
At weeks 3, 6, and 9, GTTs were conducted on mice fasted for 8 h and injected i.p. with a 20% 
glucose solution.  Data are expressed as total area under the curve (AUC) for the GTTs. Means ± 
SEM (n=9-10) without a common lowercase letter differ (p<0.05) using one-way ANOVA and 
Student’s t test.  LF, low fat; 3S, high fat diet containing 3% sugar; 3G high fat diet containing 
3% grapes; 5S, high fat diet containing 5% sugar; 5G, high fat diet containing 5% grapes.  
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Figure 3.3. Liver Gene Expression. Liver weights, liver triglyceride levels, and the expression 
of several lipogenic genes in liver of C57BL/6J mice fed a low fat diet or butter-rich, high fat 
diets with or without 3% or 5% powdered grapes for 10 weeks.  qPCR was conducted to measure 
mRNA abundance of genes associated with hepatic lipogenesis. Means ± SEM (n=9-10) without 
a common lowercase letter differ (p<0.05) using one-way ANOVA and Student’s t test.   LF, low 
fat; 3S, high fat diet containing 3% sugar; 3G high fat diet containing 3% grapes; 5S, high fat diet 
containing 5% sugar; 5G, high fat diet containing 5% grapes.  
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Figure 3.4.  WAT Gene Expression. The expression of markers of inflammation and lipid 
metabolism in epididymal and inguinal WAT of C57BL/6J mice fed a low fat diet or butter-rich, 
high fat diets with or without 3% or 5% powdered grapes for 10 weeks.  qPCR was conducted to 
measure mRNA abundance of genes associated with (A) inflammation and lipid metabolism  in 
(B) epididymal (EPI; visceral) and  (C) subcutaneous (ING; subcutaneous) WAT depots.  Means 
± SEM (n=9-10) without a common lowercase letter differ (p<0.05) using one-way ANOVA and 
Student’s t test.  LF, low fat; 3S, high fat diet containing 3% sugar; 3G high fat diet containing 
3% grapes; 5S, high fat diet containing 5% sugar; 5G, high fat diet containing 5% grapes.  
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Figure 3.5. Alterations to Intestinal Inflammation and Barrier Function. (A) Ileum mucosa 
expression of TNFα and (B) the localization of the tight junction protein ZO-1 at the apical area 
of the ileum epithelium in C57BL/6J mice fed a low fat diet or butter-rich, high fat diets with or 
without 3% or 5% powdered grapes for 10 weeks. qPCR was conducted to measure mRNA 
abundance of inflammatory genes.  Localization of ZO-1 was visualized by immunostaining of 
ileum samples (n=5).  Means ± SEM (n=9-10 for TNFα) without a common lowercase letter 
differ (p<0.05) using one-way ANOVA and Student’s t test.   LF, low fat; 3S, high fat diet 
containing 3% sugar; 3G high fat diet containing 3% grapes; 5S, high fat diet containing 5% 
sugar; 5G, high fat diet containing 5% grapes.   
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Figure 3.6. Diet Induced Alterations to Sulfidogenic Bacteria and Akkermansia 
muciniphalia. Abundance of sulfidogenic bacteria and Akkermansia muciniphilia in the intestinal 
mucosa or digesta of C57BL/6J mice fed a low fat diet or butter-rich, high fat diets with or 
without 3% or 5% powdered grapes for 10 weeks.  (A) Abundance of the sulfidogenic, Bilophila 
wadsworthia-specific, functional gene target dissimilatory sulfate reductase (dsrA-Bw) and the 
targeted sulfidogenic bacterial genera Desulfobacter (DSB) species in the ileum mucosa.  (B) The 
abundance of the probiotic Akkermansia muciniphilia in colon mucosa and digesta and in cecum 
digesta.  qPCR was conducted to measure mRNA abundance of the functional genes and bacterial 
genera.  Means ± SEM (n=9-10) without a common lowercase letter differ (p<0.05) using one-
way ANOVA and Student’s t test.  LF, low fat; 3S, high fat diet containing 3% sugar; 3G high fat 
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diet containing 3% grapes; 5S, high fat diet containing 5% sugar; 5G, high fat diet containing 5% 
grapes. Means ± SEM (n=9-10) without a common lowercase letter differ (p<0.05). 
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Figure 3.7. Diet Induced Changes to Microbial Species. Observed bacterial species in cecum 
mucosa of C57BL/6J mice fed a low fat diet or butter-rich, high fat diets with or without 3% or 
5% powdered grapes for 10 weeks. (A) Rarefaction curves of observed species are shown. 
Samples were rarified to 15,000 sequencing reads per sample. (B) Above - Area Under the Curve 
(AUC) of rarefaction curves shown for each diet group. Below – Observed species at 15,000 
sequencing reads for each diet group. LF, low fat; 3S, high fat diet containing 3% sugar; 3G high 
fat diet containing 3% grapes; 5S, high fat diet containing 5% sugar; 5G, high fat diet containing 
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5% grapes. Data are presented as Means ± SEM (n=9-10) using one-way ANOVA and Dunn’s 
test for multiple comparisons.  
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Figure 3.8. PCoA Plots of Unweighted and Weighted UniFrac Distances. LF, low fat; 3S, 
high fat diet containing 3% sugar; 3G high fat diet containing 3% grapes; 5S, high fat diet 
containing 5% sugar; 5G, high fat diet containing 5% grapes. 
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Figure 3.9. Relative Abundance of Microbial Taxa. Significantly altered relative abundances 
of microbial taxa (i.e., A- Firmicutes, B- Actinobacteria, and C- Tenericutes) found across 
C57BL/6J mice fed a low fat diet or butter-rich, high fat diets with or without 3% or 5% 
powdered grapes for 10 weeks.  Taxa shown were significantly altered based on Kruskal Wallis 
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test run using QIIME software following filtering of OTUs that were not present in 50% of 
samples. FDR corrected p values based on this analysis are shown. To conduct multiple 
comparisons relative abundances were analyzed via ANOVA followed by Dunn’s test for 
multiple comparisons. LF, low fat; 3S, high fat diet containing 3% sugar; 3G high fat diet 
containing 3% grapes; 5S, high fat diet containing 5% sugar; 5G, high fat diet containing 5% 
grapes.  Data are presented as Means ± SEM (n=9-10). Unless otherwise indicated, asterisks 
show significant differences of HF diets with or without grapes compared to LF control.  
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Figure 3.10. Principle Component Analysis (PCA) of Cecum Mucosa. The microbial relative 
abundances from C57BL/6J mice fed a low fat diet or butter-rich, high fat diets with or without 
3% or 5% powdered grapes for 10 weeks. (A) Left - PCA plot between low fat (LF) and high fat 
+ 3% grapes (HF3G) are shown. Middle – Pareto plot showing percentage of variance explained 
by principal components. Right – Histogram showing individual genera that were negatively or 
positively correlated with LF and/or HF-3G diets. (B) Same as A but showing PCA of HF-3G vs 
high fat + 3% sugar (HF-3S) groups.  
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Figure 3.11. Relationship between Body Fat and Bacterial Populations. (A) Bifidobacterium 
relative abundance is negatively correlated with body fat percentage (r = -0.53, p = 0.001) and 
inguinal fat pad weight (r = -0.48, p = 0.004) as determined by Spearman Correlation Analysis. 
(B) Heatmap showing relative abundances of taxa that were significantly correlated with body fat 
percentage.  LF, low fat; 3S, high fat diet containing 3% sugar; 3G high fat diet containing 3% 
grapes; 5S, high fat diet containing 5% sugar; 5G, high fat diet containing 5% grapes. 
 
83 
 
References 
 
 
1. Ogdan CL, Carroll MD, Kit BK, Flegal KM. Prevalence of Childhood and Adult Obesity in 
the United States, 2011-2012. JAMA 2014;311(8):806-814.  
 
2. WHO. Obesity. http://www.who.int/topics/obesity/en/. Viewed. Jan. 20, 2015. 
 
3. NIH. Obesity. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0004552/. Viewed Jan. 20, 
2015. 
 
4. Strissel KJ, DeFuria J, Shaul ME, Bennett G, Greenberg AS, Obin MS. T-cell recruitment 
and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. 
Obesity (Silver Spring) 2010;18(10): 1918-1925.  
 
5. Ding S, Chi M, Scull M, Rigby R, Schwerbrock N, Magness S, Jobin C, Lund P. High fat 
diet: bacterial interactions promote intestinal inflammation which precedes and correlates 
with obesity and insulin resistance in mice.  PLOS One 2010;5(8): e12191. 
 
6. Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S, et al. 
Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. 
Cell 2007;131(1):33-45. 
 
7. Cani P, Amar J, Iglesias M, Poggi M, Knauf C, Bastelica D, Neyrinck N, et al. Metabolic 
endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56: 1761-1772. 
 
8. Cani P, Bibiloni R, Knauf C, Waget A, Neyrinck A, Delzenne N, Barcelona R. Changes in 
gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-
induced obesity and diabetes in mice.  Diabetes 2008;57: 1470-1481. 
 
9. Delzenne N, Cani P.  Gut microbiota and pathogenesis of insulin resistance. Cur Dab Rep 
2011;11: 154-159. 
 
10. Devkota S, Wang Y, Musch M, Leone V, Fehlner-Peach Hl, Nadimpalli A, et al. Dietary-
fat-induced taurocholic acid promotes pathobiont expansion and colitis in IL10-/- mice.  
Nature 2012;487:104-108. 
 
11. Shen W, Gaskins HR, McIntosh M. Influence of dietary fat on intestinal microbes, 
inflammation, barrier function, and metabolic outcomes.  J Nutr Biochem 2014;25: 270-
280. 
 
12. Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, et al. Interactions between gut 
microbiota, host genetics, and diet relevant to development of metabolic syndromes in mice.  
ISME J 2010;4: 232-241. 
 
84 
 
13. Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, Gaskins HR. Microbial pathways in 
colonic sulfur metabolism and links with health and disease. Front Physiol 2012;3: 448.  
 
14. Rowan FE, Docherty NG, Coffey JC, O’Connell PR. Sulphate-reducing bacteria and 
hydrogen sulphide in the aetiology of ulcerative colitis. Br J Surg 2009;96(2): 151-158.  
 
15. Backhed F, Manchester J, Semenkovich C, Gordon J. Mechanisms underlying the resistance 
to diet-induced obesity in germ-free mice.  Proc Nat Acad Sci 2007;104: 979-984. 
 
16. Delzenne N, Neyrinck A, Backhed F, Cani P. Targeting gut microbiota in obesity: effects of 
prebiotics and probiotics.  Nat Rev Endocrin 2011;7: 639-646. 
 
17. Delzenne N, and Cani P. Interaction between obesity and gut microbiota: relevance to 
nutrition. Ann Rev Nutr 2011b;31: 15-31. 
 
18. Delzenne N, Neyrinck A, Cain P.  Modulation of the gut microbiota by nutrients with 
prebiotic properties: consequences for host health in the context of obesity and metabolic 
syndrome. Micro Cell Fact 2011; 10: S10 
http://microbialcellfactories.com/content/10/S1/S10. 
 
19. Cani P, Neyrinck N, Fava F, Knauf C, Burcelin R, Tuophy K, et al. Selective increases of 
bifidobacteria in the gut microbiota improve high-fat-diet induced diabetes in mice through 
a mechanisms involving endotoxemia.  Diabetolgia 2007;50: 2374-2383. 
 
20. Keperman R, Bolca S, Roger L,  Vaughan E. Novel approaches for analyzing gut microbes 
and dietary polyphenols: challenges and opportunities.  Microbiol 2010;156: 3224-3231. 
 
21. Neyrinck A, Van Hee V, Bindels L, Possemiers S, de Backer F, Cani P, et al. Polyphenol-
rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolemia in 
high-fat-induced obese mice: potential implication of the gut microbiota. Br J Nutr 
2013;109:802-809.  
 
22. Benn T, Kim B, Park YK, Wegner C, Harness E, Nam TG, et al.   Polyphenol-rich 
blackcurrant extract prevents inflammation in diet-induced obese mice.  J Nutr Biochem 
2014;25: 1019-1025. 
 
23. Van Duynhoven J, Vaughan E, Jacobs D, Kemperman R, van Velzen E, Gross G, et al. 
Metabolic fate of polyphenols in the human superorganism.  Proc Nat Acad Sci 2011;108: 
4531-4538. 
 
24. Selma M, Espin J, Tomas-Barberan F. Interactions between phenolics and gut microbiota: 
role in human health. J Agric Food Chem 2009;57: 6485-6501. 
 
25. Chuang CC, and McIntosh MK. Potential mechanisms by which polyphenol-rich grapes 
prevent obesity-mediated inflammation and metabolic diseases.  Ann Rev Nutr 2011;31: 
155-176. 
 
85 
 
26. Seymour E, Singer A, Bennink M, Parikh R, Kirakosyan A, Kaufman P, Broiling S.  
Chronic intake of phytochemical-enriched diet reduces cardiac fibrosis and diastolic 
dysfunction caused by prolonged salt-sensitive hypertension. J Gerontol A Biol Sci Med Sci 
2008; 63:1034-1042. 
 
27. Seymour EM, Bennink MR, Watts SW, Bolling SF. Whole grape intake impacts cardiac 
peroxisome proliferator-activated receptor and nuclear factor kappaB activity and cytokine 
expression in rats with diastolic dysfunction. Hypertension 2010;55:1179-85. 
 
28. Fuhrman B, Volkova N, Coleman R, Aviram M. Grape powder polyphenols attenuate 
atherosclerosis development in apolipoprotein E deficient mice and reduce macrophage 
atherogenicity.  J Nutr 2005; 135:722-728. 
 
29. Zern T, Wood R, Greene C, West K, Liu Y, Aggarwal, et al. Grape polyphenols exert a 
cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and 
reducing oxidative stress.  J. Nutr 2005; 135:1911-1917. 
 
30. Chuang CC, Shen W, Chen H, Xie G, Jia W, Chung S, McIntosh MK.  Differential effects 
of grape powder and its extract on glucose tolerance and chronic inflammation in high fat-
fed obese mice.  J Agric Food Chem 2012; 60:12458-12468. 
 
31. Shen W, Chuang CC, Martinez K, Reid T, Brown JM, Xi L, et al. Conjugated Linoleic Acid 
Reduces Adiposity and Increases Markers of Browning and Inflammation in White Adipose 
Tissue of Mice. J Lipid Res 2013; 54: 909-922. 
 
32. Shen W, Wolf PG, Carbonero F, Zhong W, Reid T, Gaskins HR, McIntosh MK. Intestinal 
and systemic inflammatory responses are positively associated with sulfidogenic bacteria 
abundance in high-fat-fed male C57BL/6J mice.  J Nutr 2014; 144: 1181-87. 
 
33. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Frederic BD, Costello EK, et al. 
QIIME allows analysis of high-throughput community sequencing data. Nat Methods 
2010;7:335–6. doi:10.1038/nmeth.f.303 
 
34. McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, et al. An 
improved Greengenes taxonomy with explicit ranks for ecological and evolutionary 
analyses of bacteria and archaea. ISME J 2012;6: 610-618.  
 
35. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naïve Bayesian Classifier for Rapid Assignment 
of rRNA Sequences into the New Bacterial Taxonomy. Appl Envir Microbiol 2007;73: 
5261-5267.  
 
36. Price MN, Dehal PS, Arkin AP.  FastTree 2 – Approximately Maximum-Likelihood Trees 
for Large Alignments. PLoS One 2010; 5, e9490.  
 
  
 
 
86 
 
37. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, 
Muccioli GG, Delzenne NM, de Vos WM, Cani PD. Cross-talk between Akkermansia 
muciniphila and intestinal epithelium controls diet-induced obesity. Proc Nat Acad Sci 
2013; 110(20): 9066-71. 
 
38. Camari A, del Bas JM, Crescenti A, Arola L. Low doses of grape seed procyanidins reduce 
adiposity and improve the plasma lipid profile in hamsters. Int J Obes (Lond) 2013;37(4): 
576-83.  
 
39. Gourineni V, Shay NF, Chung S, Sandhu AK, Gu L. Muscadine Grape (Vitis rotundifolia) 
and Wine Phytochemicals Prevented Obesity-Associated Metabolic Complications in 
C57BL/6J Mice. J Agric Food Chem 2012;60(31): 7674-81. 
 
40. Hwang YP, Choi JH, Han EH, Kim HG, Wee JH, Jung KO, Jung KH, Kwon KI., Jeong TC, 
Chung YC, Jeong HG. Purple sweet potato anthocyanins attenuate hepatic lipid 
accumulation through activating adenosine monophosphate-activated protein kinase in 
human HepG2 cells and obese mice. Nutr Resour 2011;31(12):896−906. 
 
41. Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, et al. Interactions between gut 
microbiota, host genetics, and diet relevant to development of metabolic syndromes in mice. 
ISME J 2010;4: 232-241. 
 
42. Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, Gaskins HR. Microbial pathways in 
colonic sulfur metabolism and links with health and disease. Front Physiol 2012;3:448. 
 
43. Wells HF, Buzby JC. Dietary Assessment of Major Trends in U.S. Food Consumption, 
1970-2005. US Dept Agric Econ Resour 2008; 10-14. 
 
 
 
 
 
 
 
 
 
87 
 
CHAPTER IV 
AN EXTRACTABLE, POLYPHENOL-RICH FRACTION OBTAINED FROM CALIFORNIA 
TABLE GRAPES DECREASES ADIPOSITY, INSULIN RESISTANCE, AND MARKERS OF 
INFLAMMATION IN HIGH-FAT FED C57BL/6J MICE 
 
 
     Brian Collins, Jessie Baldwin, Chia-Chi Chuang, Paula Cooney, Robin Hopkins, and  
     Michael McIntosh 
 
 
Abstract  
     The objective of this study was to determine the extent to which consuming two methanol-
extractable fractions of California table grapes reduced adiposity, hepatic steatosis, or markers of 
inflammation or lipid metabolism in mice fed a high-fat, American-type diet.  Male C57BL/6J 
mice were fed a low fat diet, a high fat (HF) diet, or a HF diet containing California table grapes 
(GP; 5% w/w), an extractable polyphenol (HF-EP) fraction from GP, a non-extractable 
polyphenol (HF-NEP) fraction from GP, or an equal combination of both fractions (HF-EP+NEP) 
for 16 weeks. Mice fed the HF-EP and HF-EP+NEP-containing diets had lower percentages of 
body fat and amounts of total white adipose tissue (WAT) and improved glucose tolerance 
compared to the HF controls.  In epididymal WAT,  the mRNA levels of the inflammatory genes 
cluster of differentiation 11c, monocyte chemoattractant protein 1, epidermal growth factor-like 
module-containing mucin-like hormone receptor 1, tumor necrosis factor alpha, and the lipogenic 
gene, acylglycerol-3-phosphate-O-acyltransferase 2 were lower in mice fed the HF-EP- and HF-
EP+NEP-containing diets compared to HF controls.  Mice fed HF-NEP and HF-EP+NEP diets 
had reduced liver weights and mice fed HF-EP+NEP diets had lower liver triglyceride levels 
compared to the HF controls. Mice fed the HF-EP+NEP diets had higher hepatic mRNA levels of 
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hormone sensitive lipase and adipose triglyceride lipase, and decreased expression of C-reactive 
protein compared to the HF controls.  Surprising, HF-GP feeding did not 
decreased adiposity, hepatic steatosis, or inflammation nor did the HF or grape diets alter markers 
of intestinal inflammation.  Taken together, these data demonstrate that the polyphenol-rich EP 
fraction from California table grapes attenuates many of the adverse health consequences 
associated with consuming a HF diet, independent of influencing intestinal inflammatory status. 
Introduction 
     Obesity has been on the rise in the U.S. since the 1960’s and affects approximately one third 
of the adult population [1]. The incidence of obesity is also increasing globally, affecting 
approximately 300 million adults worldwide [2]. Obesity is intimately associated with chronic 
inflammatory conditions that contribute to the metabolic syndrome (e.g., type 2 diabetes, 
hypertension, and cardiovascular disease) [3].  Over consumption of calories coinciding with a 
lack of physical activity are the major risk factors for obesity development resulting in expansion 
of white adipose tissue (WAT). As WAT grows beyond the capacity of the vasculature system to 
provide it with nutrients and oxygen, an increase in inflammatory signals recruit macrophages 
and other immune cells into the WAT. As the immune response progresses, the abundance of 
circulating and tissue proinflammatory cytokines and chemokines increases [4]. This 
inflammatory scenario disrupts metabolic processes which results in impaired glucose and fatty 
acid uptake and metabolism, and hemostasis, thereby contributing to the development of 
metabolic diseases. Although there is a general consensus on the metabolic consequences of 
obesity-mediated inflammation, the exact mechanisms that initiate these events are not clearly 
understood. 
     Recently, the role that gut microbes play in the development of the metabolic syndrome has 
received attention due to their sensitivity to environmental changes that can trigger obesity [5], 
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chronic inflammation [6-8], and insulin resistance [9]. Diets high in fat have been implicated in 
the reduction of microbial diversity, in particular gut barrier-protecting bacteria as well as 
increasing the abundance of deleterious bacteria [reviewed in 10]. For example, an increase in the 
ratio of Firmicutes to Bacteriodetes is positively correlated with the development of obesity and 
insulin resistance [11]. Diets rich in saturated fat [11, 12], particularly from milk [13], increase 
the abundance of sulfidogenic bacteria like Bilophila wadsworthia and Desulfovibrionaceae spp. 
which generate hydrogen sulfide gas.  Hydrogen sulfide is geno- and cytotoxic and positively 
correlated with development of ulcerative colitis, gut inflammation, irritable bowel syndrome, 
and colon cancer [13-15].  Notably, the effects of high fat (HF) diet on body weight gain are 
repressed in microbiota-free mouse models as well as fecal microbial transplants from healthy 
donors into obese subjects [16].  Therefore, interventions directed towards modifying the 
microbial composition of the gastrointestinal (GI) tract may alleviate obesity-mediated outcomes. 
     The use of non-digestible carbohydrates, fiber, or polyphenols as prebiotics shows promise as 
potential interventions for the metabolic consequences of obesity [reviewed in 13, 17-19]. 
Prebiotics are agents that selectively stimulate the growth or activities of specific microbial 
populations in the gut which translates into health benefits for the host [20].  Fiber, in particular 
inulin-type fructans, has been shown to increase the abundance of Bifidobacteria which was 
positively correlated with decreased hyperglycemia, endotoxemia, and systemic cytokine levels 
[21, 22].  Similar effects have been demonstrated in obese subjects with short term 
supplementation of gluco-oligosaccharides [23]. It is believed that the primary benefit of fiber 
fermentation by intestinal microbes is through increased productions of short chain fatty acids 
(SCFA), which have be shown to regulate the synthesis of GI peptides that influence energy 
intake (i.e., glucagon-like peptide (Glp)-1 and 2, peptide YY (Pyy), and ghrelin) as well as energy 
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storage and metabolism through interactions with G-protein receptors (Gpr) 41 and 43 [reviewed 
in 20].   
     Although much focus has been placed on the beneficial properties of fiber, polyphenols found 
in fruits and vegetables may also improve GI health [24-27].  Absorption of polyphenols is poor 
in the upper gastrointestinal tract, leading to increased availability in the lower GI tract [27]. 
Thus, polyphenols may have a significant influence on microbiota taxa and their metabolites [28]. 
Indeed, the anti-inflammatory, anti-oxidant, and anti-microbial actions of polyphenols have been 
reported to positively influence gut microbes and host inflammation [reviewed in 29]. As such, 
one potential mechanism to improve the outcomes associated with diet-induced obesity is 
increased consumption of poorly digestible food components including polyphenols. 
     Grapes and other berries are rich in polyphenols including anthocyanins [reviewed in 29], 
which have known anti-inflammatory and anti-oxidant effects [30]. These beneficial effects of 
grapes have been associated with reduced cytokine levels via suppression of nuclear factor kappa 
B (NFκB) and increased peroxisome proliferator-activated receptor (PPAR) α/γ [31]. Consistent 
with these data, we demonstrated that C57BL/6J mice consuming a HF diet (i.e., 60% kcals from 
lard) supplemented with whole powdered California table grapes  (3%, w/w) had improved 
glucose tolerance after 5 weeks and  decreased markers of inflammation ~20-50% in serum and 
WAT after 18 weeks [32].  We also demonstrated that consuming a moderate fat diet (i.e., 34% 
kcals from milk fat) supplemented with whole powdered grapes (3% or 5% w/w) reduced 
adiposity, improved liver triglyceride (TG) levels, modestly reduced WAT inflammatory gene 
expression, and lowered the cecum levels of sulfidogenic bacteria, while tending to increase the 
abundance of Akkermansia muciniphila and Allobaculum in the proximal colon and cecum, 
respectively (Chapter III). 
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     However, the identities of the bioactive fractions in whole powdered table grapes and the role 
that gut microbiota play in improvements in diet-induced obesity in mice fed grapes are 
unknown. Therefore, the objective of this study was to determine the extent to which consuming 
methanol-extractable fractions of table grapes reduced adiposity, hepatic steatosis, or markers of 
inflammation or lipid metabolism in mice fed a high-fat, American-type diet. We separated 
lyophilized powder from whole grapes into two methanol-extractable fractions; i.e., an 
extractable polyphenol (EP) fraction and a non-extractable polyphenol (NEP) fraction. These 
fractions were incorporated into a HF, American-type diet (i.e., similar in fat amount and type to 
the 75th percentile of American diets [33]).  This HF diet was fed alone or in combination with 
the EP fraction, the NEP fraction, both fractions (EP+NEP), or whole grape powder (GP; 5%, 
w/w) for 16 weeks. Body composition and glucose tolerance were measured at 5 week intervals.  
At week 16, markers of intestinal and systemic inflammation, insulin resistance, and lipid 
metabolism were measured. 
 
Materials and Methods   
Reagents and materials  
     Reference compounds procyanidin A2 (PAC-A2), procyanidin B2 (PAC-B2), catechin and 
epicatechin were purchased from Chromadex (Irvine, CA).  4-dimethylaminocinnamaldehyde 
(DMAC), Folin-Ciocalteu reagent, and trifluoroacetic acid (TFA) were purchased from Sigma-
Aldrich Inc. (St. Louis, MO). All organic solvents were HPLC grade and obtained from VWR 
International (Suwanee, GA).  
 
Extraction and polyphenol enrichment 
     Freeze-dried grape powder (200 g x 5 batches) was blended each with 1 L 50% acidified 
methanol (0.1% TFA).  The mixture was centrifuged (Sorvall RC-6 plus, Asheville, NC) at 4000 
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rpm for 10 min, and the supernatant was collected. A sample from the combined supernatants (2 
L) was evaporated and freeze-dried to afford the crude extract. The rest of aq-methnol extract was 
evaporated to remove the organic solvent, and then loaded to Amberlite XDA-7 resin, stirred for 
20 minutes, and the supernatant was discarded. The resin was washed with water to get rid of all 
free sugars and organic acids. The polyphenols were eluted from the resin with 100% methanol, 
organic solvent was evaporated under vacuum, and the remaining aqueous extract was freeze-
dried to afford the EP fraction. The pelleted material (plant debris after extraction) was put in a 
vacuum oven (45 ºC) to get rid of the organic solvent before freeze-drying to afford the NEP 
fraction. 
 
Alkaline hydrolysis of NEP fraction 
     Alkaline hydrolysis of NEP fraction was performed according to Yang et al. [34] with some 
modifications. In 15 mL centrifuge tube, 2.0 mL of 4 M NaOH were added to 0.5 g NEP, flushed 
with nitrogen, closed and incubated for 1 hour at room temperature. The mixture was adjusted to 
pH 7 with drops of concentrated hydrochloric acid, than loaded onto a column packed with celite 
at a ratio 1:2 v/w.  The hydrolyzed polyphenols were eluted with 30 mL methanol-ethyl acetate 
(20:80 v/v), and evaporated to dryness. 
 
Determination of total phenolics, anthocyanins and proanthocyanidins 
     Total phenolics (TP) were determined in EP and NEP fraction hydrolysates with Folin-
Ciocalteu reagent [35]. Concentrations were expressed as mg/L gallic acid equivalents. Total 
monomeric anthocyanin (ANC) content was measured in EP using the pH differential 
spectrophotometric method [36], and expressed as cyanidin glucoside equivalent. Total 
proanthocyanidin content (PAC) was determined in EP using the DMAC method as previously 
described [37], and quantified as procyanidin A2 equivalent. 
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HPLC profile analyses of anthocyanins and proanthocyanidins 
     HPLC analyses were conducted according to the previously reported protocols [38]. 
 
Animals 
     Four-week old, male C57BL/6J mice were obtained from Jackson Laboratories (Bar Harbor, 
ME, USA) and acclimated on a standard chow diet for 1 week. Mice were housed in pairs, 
maintained at a temperature of 22
◦
C with 50% humidity, and exposed to a 12 h light/ 12 h dark 
cycle. Mice received food and water ad libitum and measures of body weight and food intake 
were conducted once and twice per week, respectively. All experimental procedures were 
performed under ethical standards and approved by the Institutional Animal Care and Use 
Committee of the University of North Carolina at Greensboro. 
 
Diets 
     Animals were randomly assigned to one of six dietary treatments (n=13 per treatment group) 
as follows: low fat (LF; 10% of energy from fat), HF (45% of energy from fat), HF plus 
extractable polyphenol fraction (HF-EP), HF plus non-extractable polyphenol fraction (HF-NEP), 
HF plus extractable and non-extractable polyphenol fraction (HF-EP+NEP) and HF plus 5% 
powdered grapes (HF-GP) (Table 4.1). The HF diets consisted of approximately 10.7% energy 
from soybean oil, 9.8% of energy from butter, 7.8% energy from lard, 12.2% energy from 
shortening, and 4.5% energy from beef tallow [33, 39]. Thus, the HF diets were rich in fat with 
the proportion of the sources of fat mimicking an American-type diet [33]. The amounts of EP 
and NEP fractions that were added to the HF diets were equal to their relatively amounts in the in 
the 5% powdered whole grape diet (i.e., grape powder contains 2.3% and 6.9% EP and NEP, 
respectively). The lyophilized (i.e., powdered) California table grapes were kindly provided by 
the California Table Grape Commission and consisted of a mixture of red, green, and purple 
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seeded and seedless grapes. The 5% dietary level of grapes is comparable to 15 human servings 
of grapes. Because the extraction process removes the sugar fraction in grapes, a mixture of 
fructose and glucose was added to the HF, HF-EP, HF-NEP, and HF-EP+NEP diets to control for 
the sugar content of the powdered grape diet. Detailed composition of the diets is illustrated in 
Table 4.1.  
 
Intraperitoneal glucose tolerance tests (GTT)s and fasting insulin levels  
     Intraperitoneal (i.p.) GTTs were performed on weeks 7, 12, and 16 on non-anesthetized mice. 
Mice were fasted for 8 h and given an i.p. injection of glucose (i.e., 20% solution at 1 g/kg body 
weight). Blood from the tail vein collected at baseline and 5, 15, 30, 60, and 120 minutes post-i.p. 
glucose injection was used to quantify glucose levels using a Bayer Contour blood glucose 
monitor and strips (Bayer Healthcare, Tarrytown, NY, USA). Plasma insulin levels were detected 
using an ultrasensitive mouse insulin kit (Crystal Chem, Inc, Downers Grove, IL). The 
homeostasis model assessment method (HOMA) for insulin resistance (IR) was used employing 
the following formula: [fasting insulin concentration (ng/ml) x 24 x fasting glucose concentration 
(mg/dl)] / 405 [32]. 
 
Body fat measurements via Dual X-Ray Absorptiometry (DEXA) 
     Percent body fat was measured using DEXA on a GE Lunar Prodigy Advanced System (GE 
Healthcare, Milwaukee, WI) at weeks 6, 11, and 15. During the measurement, mice were lightly 
anesthetized with isoflurane using a SomnoSuite Small Animal Anesthesia System with 
Integrated Digital Vaporizer isoflurane system. Measurements were taken in duplicate or 
triplicate to reduce the possibility of error and values expressed are an average of the two 
measurements.  
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Tissue collection 
     After 16 weeks of dietary intervention, mice were fasted for 8 h and euthanized via isoflurane-
induced anesthesia followed by cardiac puncture. Plasma was collected at the time of harvest. 
Four WAT depots were collected; epididymal, mesenteric, inguinal, and retroperitoneal. 
Additionally, livers were harvested and intestinal mucosa and digesta were collected from the 
duodenum, jejunum, ileum, cecum, or proximal or distal colon. Weights of the WAT depots and 
liver were recorded and all collected samples were immediately snap-frozen in liquid nitrogen 
and stored at -80
o
C until analysis.  
 
Liver and plasma TG levels 
     Liver TG content was measured as previously described [40]. Plasma TG content was 
determined using a commercial assay from Thermo Scientific and was conducted following the 
manufacturer’s protocol (Infinity TG assay #TR22421 and TG standards #TG22923; Norcross, 
GA).  
 
Liver Oil-Red-O Staining 
     Liver tissues were frozen in OCT compounds, cut at 5 μm, and mounted on slides. The 
sections were fixed with 10% formalin for 10 minutes and then the slides were washed with 
deionized water for 5 minutes. Fixed tissues were then rinsed with 60% isopropanol for 5 
minutes. To prepare Oil red O stock, 0.5 g of Oil red O (Sigma-Aldrich) was mixed with 100 mL 
of isopropanol. To prepare Oil red O working solution, 30 mL of Oil red O stock was mixed with 
20 mL of distilled water and filtered using a 0.24 µm vacuum filter. Samples were submerged in 
the working solution for 15 minutes, briefly rinsed with 60% isopropanol, and then rinsed with 
deionized water for 30 seconds before imaging. 
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RNA extraction and qPCR 
     Adipose and intestinal samples were homogenized in QIAsol reagent and total RNA was 
extracted using QIAgen mini lipid kit obtained from Qiagen (Valencia, CA). For hepatic samples, 
a QIAgen mini universal kit from Qiagen was used. The quality and concentration of RNA were 
examined using absorbance at 260 nm and integrity determined using the absorbance ratio of 
260/280 on a Nanodrop ND-1000 Spectrophotometer (Thermo Scientific, Wilmington, DE). 
Complementary DNA was created by reverse transcription using 1 ug of RNA and a high 
capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA) according to manufacturer’s 
protocols. qPCR was performed in a 7500 FAST Real Time PCR system (Applied Biosystems). 
The expression of different genes related to inflammation, lipogenesis, and lipolysis in WAT 
depots and liver were measured using Taqman Gene expression assays purchased from Applied 
Biosystems. TATA-binding protein (Tbp) was the endogenous reference gene utilized for all 
assays and fold differences in gene expression were calculated as 2
−ΔΔCt
. 
 
Statistical Analysis 
     Data were analyzed using a one-way ANOVA and Student’s t tests to compute individual 
pairwise comparisons of means (p<0.05). Bonferroni’s posthoc tests were also performed for 
specific comparisons where appropriate. Analyses were conducted using the JMP software 
program version 10.0 for Windows (SAS, Cary, NC).  Data are expressed as means + S.E.M. 
Results  
Polyphenol content and profile of EP, NEP, and GP 
     Polyphenol analysis revealed that the weight percentages of polyphenols in the EP and NEP 
fractions were 2.26% and 6.91% respectively.  The EP fraction contained 180.0 mg/g of total 
phenolics and the NEP fraction contained 10.5 mg/g of total phenolics.  Total anthocyanin and 
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proanthocyanidin content of the EP fraction was 37.8 mg/g and 305.5 mg/g, respectively, whereas 
these polyphenols were not detectable in the NEP fraction (Table 4.2). Individual anthocyanin 
analysis revealed that the most abundant anthocyanins present in the EP fraction were peonidin-3-
O-glucoside (36.6 u/mg), malvidin-3-O-glucoside (30.8 u/mg), and peondin-3-O-cis (6”-O-p-
coumaryl)-glucoside (28.5 u/mg) (Table 4.3). The profile of the degree of polymerization of the 
proanthocyanidins in the EP fraction is shown in (Fig. 4.1).  
 
EP fraction with or without NEP fraction lowers body fat gain  
     Body weight gains and energy intakes were greater in all HF-fed mice compared to the LF 
control mice (Table 4.4).  There was no difference in the energy intake between all of the HF-fed 
mice, with the exception of the HF-EP+NEP group that consumed approximately 10% fewer 
calories than the HF controls (Table 4.4). Mice fed the HF-EP and HF-EP+NEP diets had lower 
body weight gains (Table 4.4; ~28% and 40%, respectively) and body fat percentages than the HF 
controls (Fig. 4.2; 27% and 37%, respectively). Mice fed the HF-EP, HF-NEP and HF-EP+NEP 
diets had lower total WAT depot weights compared to HF controls (Fig.4.2).  Paradoxically, mice 
fed the HF-GP diet did not have improvements in body fat percentage, body weight, and total 
WAT depot weights compared to the HF controls.    
 
EP fraction improves glucose disposal, insulin resistance, and hypertriglyceridemia  
     To assess the impact of grape consumption on glucose disposal and insulin resistance, GTTs 
were conducted at weeks 7, 12, and 16, and fasting plasma insulin and HOMA-IR were measured 
at week 16, respectively. Mice consuming the HF control diet had impaired GTTs at all three time 
points compared to the LF controls (Fig. 4.3A). This HF diet impairment was attenuated at all 
three time points in mice fed the HF-EP diet. Mice fed the HF-NEP and HF-EP+NEP diets had 
improved GTTs at weeks 12 and 16 compared to the HF controls. HOMA-IR index calculations 
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at week 16 indicated that mice consuming the HF-EP+NEP fraction had improved insulin 
sensitivity compared to the HF controls (Fig. 4.3B). Surprisingly, consuming grapes did not 
significantly improve GTT, fasting plasma insulin, and HOMA-IR measurements.  Mice fed the 
HF-EP and the HF-EP+NEP diets had lower plasma TG levels compared to the HF-fed controls 
(Fig. 4.3C). 
 
Grape fraction consumption lowers hepatic TG levels and alters the expression of genes 
associated with lipid metabolism and inflammation  
     Liver tissue was analyzed to assess the impact of the diets on liver TG levels and markers of 
lipogenesis, lipolysis, and fatty acid oxidation. Mice consuming the HF control diet had greater 
liver weights, TG content, and mRNA levels of the lipogenic genes Pparγ and Fas compared to 
the LF-fed mice (Fig. 4.4).  Compared to LF controls, HF feeding also increased gene expression 
of steoryl regulatory element binding protein 1 (Srebp-1c), and stearoyl-CoA desaturase 1 (Scd1), 
which was not effected by whole grape or grape fraction feeding (Figure 4.4). Mice consuming 
the HF-NEP and HF-EP+NEP diets had lower liver weights and mice consuming the HF-
EP+NEP diet had lower liver TG content compared to HF controls. Mice fed the HF-EP and HF-
EP+NEP diets had greater mRNA levels of hormone sensitive lipase (Hsl), while mice fed the 
HF-EP+NEP diet had increased mRNA levels of adipose triglyceride lipase (Atgl) compared to 
HF controls (Figure 4.4).  HF feeding increased the hepatic gene expression of the inflammatory 
marker C-reactive protein 1 (Crp1), which was attenuated by HF-EP and HF-EP+NEP feeding 
(Figure 4.4). Interestingly, all mice consuming HF diets had ~60% lower mRNA levels of 
phosphoenolpyruvate carboxykinase (Pck1), a marker of gluconeogenesis.  No treatment 
differences in the expression of carnitine palmitoyltransferase 1-a (Cpt1a) were detected (data not 
shown).  Hepatic oil-red-o staining indicated greater lipid content in the livers of mice fed the HF 
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control diet compared to the LF controls, which was attenuated by HF-EP, HF-NEP, and HF-
EP+NEP consumption (Fig. 4.5).  
 
EP fraction with or without NEP fraction improves the expression of WAT genes associated with 
inflammation and lipid metabolism  
     To determine if the negative metabolic effects caused by HF-feeding were associated with 
inflammation in WAT, mRNA levels of several proinflammatory genes were measured in 
inguinal (subcutaneous) and epididymal (visceral) WAT.  In inguinal WAT, mice fed the HF 
control diet had greater mRNA levels of cluster of differentiation 11c (Cd11c) and monocyte 
chemoattractant protein 1 (Mcp1) compared to LF controls (Fig.4.6A).  This HF-induced increase 
was attenuated in mice fed the HF-EP and HF-EP+NEP diets.  In epididymal WAT, HF-feeding 
increased mRNA levels of Cd11c, Mcp1, tumor necrosis factor alpha (TNFα), and epidermal 
growth factor-like module containing mucin-like hormone receptor 1 (Erm1; F4/80 human 
orthologue) compared to LF controls (Fig. 4.6B).  Consistent with the inguinal data, mice fed the 
HF-EP and HF-EP+NEP diets had lower mRNA levels of these genes compared to the HF 
controls.   
     To determine whether the reduction in adiposity observed with feeding of HF-EP, HF-NEP, 
and HF-EP+NEP diets was associated in alterations in lipid metabolism, inguinal and epididymal 
WAT were examined for markers of; (i) lipogenesis (i.e., Pparγ, Srebp1c, Scd1, acylglycerol-3-
phosphate-O-acyltransferase 2 (Agpat2), fatty acid synthase (Fas), glycerol-3-phosphate 
acyltransferase2 (Gpat2)), (ii) lipolysis (i.e., Atgl (iii) beta-oxidation (i.e., carnitine 
palmitoyltransferase 1-b (Cpt1b), Pparα), (iv) SCFA receptors (i.e. GPR43), and (v) plasminogen 
activator inhibitor-1 (Pai-1). In inguinal WAT, mice fed the HF diet had greater expression levels 
of Agpat2, which were lower in the HF-EP and HF-EP+NEP groups (Fig. 4.7A). Cpt1b gene 
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expression was lower in mice fed the HF-EP, HF-EP+NEP diets compared to the HF-fed mice. 
No treatment differences in gene expression were observed for Srebp1c, Scd1, Fas, Gpat2, Atgl, 
and Pparα.   
     In epididymal WAT, mice consuming the HF diet had higher mRNA levels of Agpat2, a 
marker of TG biosynthesis, compared to LF controls (Fig. 4.7B).  Feeding HF-EP and HF-
EP+NEP attenuated this HF-induced increase in Agpat2 expression.  Additionally, mice fed the 
HF diet-had lower levels of Pparγ compared to LF controls. The expression of Pparα, a marker 
of beta oxidation, was reduced in mice fed the HF control and the GP diets compared to LF 
controls.  Surprisingly, HF feeding increase the mRNA levels of Cpt1b, beta-oxidation marker, 
which was reduced by HF-EP and HF-EP+NEP feeding. Additionally, mice fed the HF-EP+NEP 
diet had lower mRNA levels of GPR43, a SCFA-activated receptor associated with increased 
energy harvest, compared to HF- and LF-fed controls. No differences in gene expression in 
epididymal WAT were observed for Srebp-1c, Scd1, Fas, Gpat2, and Atgl (data not shown). 
 
Minimal influence of HF-feeding and grape fraction consumption on markers of intestinal 
inflammation  
     Given the reported adverse effects of consuming saturated fats [reviewed in 10] on intestinal 
health, and potential prebiotic impact of grapes, we measured the effects of the diets on markers 
of intestinal inflammation and barrier function. For inflammatory status, the mRNA levels of 
Cd11c, Cd68, Erm1, Mcp1, Tnfα, toll-like receptor 4 (Tlr4), and interleukin (Il)1b in ileum and 
proximal colon mucosa and the activity of ileal myeloperoxidase were measured. Unexpectedly, 
the mRNA levels of proinflammatory genes were not increased in the ileal mucosa of HF- fed 
mice compared to the LF controls. Equally surprising, mice consuming the HF-GP diets had 
greater mRNA levels of Tlr4 and Cd68 compared to the HF-fed mice (Fig. 4.8A). Although the 
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activity of myeloperoxidase, an enzyme expressed neutrophils and indicative of neutrophil 
infiltration, was ~50%  lower in the ileal mucosa of mice consuming the HF-EP and HF-EF+NEP 
diets compared to the HF-fed mice, these differences were not statistically significant (Fig. 4.8A). 
Similarly, the expression of Tlr4 was greater in the colonic mucosa of HF- GP fed mice compared 
to the HF controls (Fig. 4.8B).  Two of the proinflammatory genes measured in the colonic 
mucosa where increased by HF feeding (i.e., Cd11c, Cd68) and only Cd68 was attenuated in mice 
consuming the HF-EP+NEP diet (Fig. 4.8B).  
 
 Influence of grape fractions on intestinal L-cell gene expression  
     Intestinal microbial metabolites impact local and systemic health, in part, by influencing 
fermentation products (e.g., SCFA), energy harvest, and the release of endocrine signals from L-
cells located in the mucosa epithelium. Locally, these metabolites influence the integrity of the 
mucosa barrier and systemically impact energy balance and carbohydrate and lipid metabolism 
[20].  Therefore, we determined the influence of the dietary treatments on the induction of genes 
associated with SCFA receptors (e.g., Gpr41, -43, and -119) and two of their downstream targets 
(e.g., Glp and Pyy) in the ileum and proximal colon. Mice fed the HF-EP, HF-NEP, and HF-
EP+NEP diets had greater mRNA levels Gpr43, but not Gpr41, in the ileum mucosa compared to 
the HF controls (Fig. 4.9A). Mice fed the HF-EP+NEP and the HF-GP diets had lower mRNA 
levels of Gpr41 in the ileum mucosa compared to the HF controls. Mice fed the HF-GP diet has 
the highest levels of Glp compared to all other treatments (Fig.4.9A). In contrast, mice fed the HF 
diet had higher mRNA levels of Gpr43 in the proximal colon compared to the HF-NEP, HF-
EP+NEP, and HF-GP groups (Fig. 4.9B). Lastly, HF-feeding increased Pyy mRNA levels in the 
proximal colon, which were lower in mice fed the HF-EP+NEP diet.  
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Discussion 
Rationale and significance of this study 
     We previously demonstrated that feeding whole GP in conjunction with a HF diet (i.e., 34% 
kcals from fat; 3% from soybean oil and 31% from milk fat, which was similar to the amount of 
fat consumed by Americans in the 50
th
 percentile [33] for 10 weeks modestly reduced adiposity 
(3% and 5% GP), hepatic steatosis (5% GP), and the ileal mucosa abundance of the deleterious 
sulfidogenic bacterium species DSB and a sulfidogenic gene drsA-Bw (3% GP),  and increased 
the proximal colon mucosa abundance of the beneficial bacterium Akkermansia muciniphila (5% 
GP) and the localization of the tight junction protein ZO-1 on the apical epithelial surface of the 
ileum (3% and 5% GP). However, consuming the HF diet for 10 weeks only modestly increased 
adiposity, insulin resistance, and several markers of inflammation in epididymal (visceral) WAT, 
and had no effects on markers of intestinal inflammation.  Therefore, we conducted the current 16 
week study using a higher level of dietary fat (i.e., 45% kcals) and a fatty acid profile that was 
similar to Americans in the 75
th
 percentile (i.e., soybean oil, butter, lard, shortening, and beef 
tallow [33] to enhance the metabolic consequences of diet-induced obesity. We also wanted to 
know which fraction of GP was responsible for reducing adiposity and its potential metabolic 
complications.  Therefore, we examined the effects of whole GP (i.e., 5%) and two isolated 
fractions of grapes (i.e. methanol derived EP and NEP fractions which were fed at amounts equal 
to those in 5% GP) on the development of obesity, steatosis, glucose intolerance, and WAT 
inflammation in C57BL/6J mice fed a HF diet similar to Americans. The EP fraction contained ~ 
16 times more polyphenols, particularly anthocyanins (i.e., glucosides of anthocyanidins; Table 
4.3) and proanthocyanidins (i.e., polymers of anthocyanidins formed by the condensation of 
flavans; Table 4.2) , than the NEP fraction. The results indicate that in the context of HF feeding, 
consumption of the polyphenol-rich, EP fraction, alone or in combination with the NEP fraction, 
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attenuated diet-induced obesity, insulin resistance, steatosis, and chronic inflammation in WAT.  
However, consuming whole GP had no beneficial impact on the outcomes measured, and reasons 
for this lack of an effect are unclear. 
     
Potential mechanisms by which anthocyanin-rich EP fraction suppresses adiposity and 
inflammation and improves insulin sensitivity  
     Anthocyanins and proanthocyanidins are groups of flavonoids present in relatively large 
amounts in table grapes. Anthocyanins give these berries their unique colors.    Our phenolic 
analysis indicated that the most abundant anthocyanins found in California table grapes are 
malvidin-3-O-glucoside, peonidin-3-O-glucoside, and cyanidin-3-O-glucoside.  While studies 
have demonstrated anti-obesity and anti-diabetic effects of anthocyanins [reviewed in 41], studies 
focusing on the effects of feeding whole grapes and grape fractions feeding in subjects consuming 
a diet similar in fat amount and types to the American diet are lacking.  Consistent with our 
anthocyanidin-rich EP data, mice consuming a HF diet (i.e., 60% kcals from fat, primarily lard) 
supplemented with anthocyanin-rich muscadine grape or wine extracts for 15 weeks had lower 
body weights, plasma glucose and TG levels, insulin resistance, and CRP levels compared to 
controls (42).  Also, dietary supplementation of grape seed procyanidins has been demonstrated 
to prevent body weight gain, reduces WAT inflammatory markers (i.e. Tnfα, Il-6, Crp) in high-
fat-fed rats (43).  Similar effects were observed with grape seed extract supplementation 
including reductions in weight gain, WAT weights and blood lipid levels in HF fed mice (44), 
and improvements insulin sensitivity and reductions in oxidative stress in high-fructose fed rats 
(45). These findings are consistent with our data demonstrating that EP-fed mice had less body 
weight gain, reduced WAT weights, lower plasma TG, improved insulin sensitivity, and reduced 
markers of inflammation in WAT (i.e. Cd11c, Mcp1, F4/80). 
104 
 
     While research is lacking on the effects of grape anthocyanins specifically, anthocyanins from 
other dietary sources have been well documented in the literature.  Anthocyanins have been 
demonstrated to consistently exert anti-inflammatory and anti-obesity effects in vitro, and in 
some instances in vivo.  For example, anthocyanins from black soybeans reversed weight gain, 
reduced the levels of serum TG and cholesterol, and increased the levels of high-density 
lipoprotein (HDL) (46). These findings are consistent with our data demonstrating that mice fed 
the anthocyanin-rich EP fraction had reduced body weight gain and plasma TG levels compared 
to the HF controls.  Also, anthocyanins from purple corn prevented HF diet induced increases in 
body weight and adipose tissue weights in mice (47). Similarly, in HF (60% kcals from lard) fed 
mice, purified anthocyanins from blueberries prevented body weight gain and fat gain compared 
to controls (48).  Additionally, tart cherries, similar to grapes with respect to anthocyanin profile, 
reduced fat mass and WAT markers of inflammation including Il-6 and Tnfα. (49).  These data 
are consistent with our data demonstrating that the anthocyanin-rich EP fraction decreased body 
weight gain, fat mass, plasma TG levels, and WAT expression of inflammatory markers including 
Tnfα, Mcp1, Cd11c, F4/80. Additionally, 3T3-L1 preadipocytes treated with anthocyanins had 
decreased TG accumulation and gene and protein expression of Pparγ and Fas (50). While we did 
not observe alterations in expression of Pparγ and Fas within the WAT, we did observe that mice 
fed the EP fraction had reduced expression of the lipogenic gene Agpat2. 
     We also demonstrated in this study that mice fed the anthocyanin-rich EP fraction had 
improved glucose tolerance and insulin sensitivity compared to the HF controls.  Similar effects 
of improvements in glucose tolerance were observed with supplementation of anthocyanins from 
Maqui Berry in HF fed mice (51) and also with supplementation of anthocyanins from Cornelian 
cherry in HF fed mice It has been reported that cyanidin-3-O-glucoside supplementation 
improves insulin sensitivity in diabetic mice via down-regulation of retinol binding protein and 
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up-regulation of GLUT4 gene expression (53). This could be a potential mechanism by which the 
EP fraction improved glucose tolerance and insulin sensitivity.  
     One novel finding of our study was that the anthocyanin-rich EP fraction increased expression 
of Hsl, a gene associated with lipolysis, and reduced expression the lipogenic-related gene, Pparγ 
within the liver. This indicates that the EP fraction may reduce steatosis through up-regulation of 
lipolytic pathways and suppression of lipogenic pathways.  Further research examining the effect 
of the EP fraction on these pathways would be beneficial to better understand the mechanisms by 
which the EP fraction reduces adiposity or steatosis.   
 
Relationship of intestinal inflammation to systemic inflammation 
     High fat feeding is known to increase body fat mass and has been shown to consistently 
induce chronic, low grade inflammation systemically [reviewed in [54]. However, the link 
between diet and intestinal inflammation has not been as extensively studied.  In the current 
study, HF feeding did not increase markers of inflammation in the ileum or proximal colon after 
16 weeks, nor was there any beneficial effect of GP or grape fraction consumption.  However, 
other research has shown that HF diets can trigger intestinal inflammation or endotoxemia that 
may increase systemic inflammation, possibly due to intestinal dysbiosis and barrier dysfunction 
[7-13].  For example, mice fed a HF diet had increased levels of saturated fatty acids and 
lipopolysaccharide (LPS) within intestinal tissue samples resulting in increased Tnf-α and Il-6 
expression through activation of the toll-like receptor Tlr4/Nf-κB signaling pathway [18].  Mice 
fed a HF diet were also more susceptible to dextran sulfate sodium (DSS) induced colitis [19].  
As a result the immune response was reduced which was associated with an increase in non-
CD1d-restricted natural killer T (NK T) cells, which produce inflammatory cytokines similar to 
those secreted by adipocytes, decreasing the number of regular NK T cells normally found in the 
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colon.  In addition, dietary supplementation with bioactive food components such as grape seed 
extract and red wine extracts has been shown to improve the intestinal health of subjects fed HF 
diets.   For example, chronic consumption of grape seed extract increases tight junction protein 
and reduces fecal calprotectin; a neutrophil protein used as a marker of intestinal inflammation 
[55], and attenuates inflammatory signaling in chemically-induced colitis [56]. Furthermore, in 
Wistar rats treated with concentrated grape juice, induced colitis was attenuated [57]. In the 
current study, consumption of the EP and EP+NEP fractions notably attenuated several 
proinflammatory markers in the WAT, but only EP+NEP decreased the expression of the 
macrophage markers Cd68 in the proximal colon.  Although the activity of the neutrophil enzyme 
myeloperoxidase was decreased by 40-50% in the EP and EP+NEP groups compared to the HF 
controls, these differences were not statistically significant. However, measuring the protein 
levels of inflammatory markers and the activity of myeloperoxidase and alkaline phosphates in 
the colon may provide more insight. Alternatively, the intestinal linkage to systemic effects of HF 
and grape fraction feeding may be due to changes in gut microbiota, as indicated in our first study 
(Chapter III).  
     The intestinal microbiota is highly influenced by environmental changes which have been 
linked to alterations in host health and energy intake.  Research has shown that alteration to the 
gut microbiota by HF feeding can result in increased adiposity, insulin resistance and increased 
inflammatory cytokines and chemokines [58 -60].  This has been linked to impaired gut barrier 
function (i.e., the inhibition of tight junction protein production or reduction of mucin secretion 
from goblet cells) leading to endotoxemia [61,62] and impaired regulation of energy intake and 
metabolism through activation TLR-dependent enteroendocrine signaling pathways resulting in 
impaired neural response to leptin [reviewed in 63].  Conversely, microbial consumption of 
dietary fiber and polyphenols such as those found in grapes, may reduce intestinal and systemic 
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inflammation through regulation of energy intake and improved intestinal barrier function 
[reviewed in 64].  Grape polyphenols in particular may have a major impact on the microflora of 
the large intestine. For example, red wine grape polyphenols given to humans for 4 weeks 
significantly increased the number of Enterococcus, Prevotella, Bacteriodetes, and 
Bifidobacterium bacteria which correlated to improved blood pressure, and serum levels of TG, 
total cholesterol, and CRP [65].  Further evidence of the prebiotic effects of grape consumption 
can be seen in rats given grape pomace juice which increased fecal counts of Lactobacillus and 
Bifidobacterium which consequently also resulted in an increase in the concentration of primary 
bile acids, cholesterol, and cholesterol metabolites while decreasing the concentration of 
secondary bile acids [66].  This suggests that alteration of the microflora by grape polyphenols 
may inhibit cholesterol absorption thus improving circulating levels. Indeed, fermentation of fiber 
and polyphenols by colonic microbes into SCFA has been shown to regulate energy intake and 
metabolism through stimulating the release of glycoproteins (e.g., Glp-1, Glp-2, and Pyy) by 
activating Gpr43 and Gpr41 on enteroendocrine cells [reviewed in 67].  Butyrate in particular is 
also beneficial to intestinal homeostasis as an endothelial energy source as well as through 
increasing tight junction protein synthesis and mucin secretions [68, 69]. In the current study, the 
expression of several markers of enteroendocrine cell secretions associated with SCFA activation 
were upregulated.   However, these results were conflicting between the ileum (i.e., Gpr43 
mRNA levels increased by the EP, NEP, EP+NEP diets) and the proximal colon (i.e., Gpr43 
mRNA levels increased by HF diet only).  Future analysis of the intestinal microbiota 
composition, protein levels of Gprs, Pyy, and Glp1/2 levels, and gut barrier function should 
provide more insight about the extent to consuming HP, GP, and grape fractions influences these 
intestinal biomarkers.   
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Limitations and unanswered questions 
     The beneficial systemic effects of consuming the EP grape fraction may be due to its rich 
anthocyanidin content.  However, the whole GP diet did not have the same positive outcomes as 
the EP or NEP diets.  There were several differences in the design of our previous (Chapter III) 
and current study that may have contributed to these conflicting results.  The previous research 
was shorter (10 weeks) compared to the current study (16 weeks) and the diet composition with 
regards to fat (i.e., primarily butter fat at 34% kcals versus a combination of butter, lard, 
shortening, and beef tallow at 45% kcals from fat, respectively) and fiber (50 g versus 40 g 
cellulose, respectively). The additional 6 weeks in length of the current study may have caused 
any potential health benefits of the whole grape diet to have diminished. Yet, by week 10 of the 
second study, there were no differences between the HF and GP group in regards to body weight, 
body fat percentage, and glucose tolerance.  Furthermore, there may have been a different 
interaction between the GP and the four types of fats in the current study versus the sole fat 
source (butter) in the first study (i.e., the polyphenols in the  whole GP may interact with butter 
differently than with the other fat sources, thereby affecting their bioaccessibility and 
bioavailability). Indeed, the fat content of the diet can differentially impact polyphenol digestion 
and absorption [70].  Such an interaction may have enabled the polyphenols to inhibit lipase 
activity, possibly affecting the rate of fat absorption.  The increase in calories in the current study 
may have been too excessive for the beneficial effects of the whole GP to have a positive impact 
on lipid absorption as well.  In order to increase the percentage of fat in the current study, the 
amount of cellulose and corn starch were reduced compared to the previous study. The alteration 
in carbohydrate and fiber content may have resulted more time for increased absorption of 
macronutrients. Such a scenario would result in greater energy harvest, adipogenesis, and 
triglyceride synthesis in the liver and WAT, independent of any effects by the grape powder.  
109 
 
Furthermore, the extraction process of the anthocyanin rich fraction may have increased the 
bioaccessibility and subsequent bioavailability of the polyphenols within the powder by liberating 
them from interactions within the food matrix, making them more susceptible to interactions with 
brush boarder enzymes potential enhancing their absorption in the small intestine.  Similarly, 
liberation of the polyphenols may have altered the luminal environment, thereby improving the 
confluence of beneficial bacteria. 
     Another possible impact of the reduced fiber may have been on the microbiota of the large 
intestine, as fiber is a primary energy source for a vast majority of microbes in this environment.  
As such, the reduced fiber may impact the production of SCFAs as well as reduce the diversity of 
the microbiota, which typically results in intestinal inflammation, impaired barrier function, or 
adverse systemic effects.  Interestingly, although the GP diet had no positive health impact in the 
second study, the extractable polyphenol fraction did have a positive effect on reducing HF-
mediated adiposity and systemic inflammation. Future studies should focus on feeding single 
anthocyanins and there combinations (i.e., candidates in Table 4.3) in conjunction to a HF diet to 
see which may be the most effective. 
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Table 4.1. Diet Formulation 
Ingredients (gram) LF HF GP EP NEP EP+NEP 
Casein 200 200 200 200 200 200 
L-Cystine 3 3 3 3 3 3 
Corn Starch 306.2 73.2 73.2 73.2 73.2 73.2 
Maltodextrin 10 125 94 94 94 94 94 
Fructose 0 21.9 0 21.9 21.9 21.9 
Dextrose, Monohydrate 0 21.9 0 21.9 21.9 21.9 
Sucrose 68.8 139 139 139 139 139 
Cellulose 50 40 40 40 40 40 
Soybean Oil 25 48.8 48.8 48.8 48.8 48.8 
Butter 0 44.7 44.7 44.7 44.7 44.7 
Lard 20 35.3 35.3 35.3 35.3 35.3 
Shortening 0 55.6 55.6 55.6 55.6 55.6 
Beef Tallow 0 20.3 20.3 20.3 20.3 20.3 
Mineral Mix 10 10 10 10 10 10 
DiCalcium Phosphate 13 13 13 13 13 13 
Calcium Carbonate 5.5 5.5 5.5 5.5 5.5 5.5 
Potassium Citrate 16.5 16.5 16.5 16.5 16.5 16.5 
Vitamin Mix 10 10 10 10 10 10 
Choline Bitartrate 2 2 2 2 2 2 
NEP Grape Fraction 0 0 0 0 2.97 2.97 
EP Grape Fraction 0 0 0 0.97 0 0.97 
Grape Powder 0 0 43 0 0 0 
Total 1055.1 854.7 857.5 855.7 857.7 858.7 
 
*LF, low fat control; HF, high fat sugar control; GP, grape powder; EP, extractable polyphenol 
fraction; NEP, non-extractable polyphenol fraction. 
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Table 4.2. Phenolic Composition of Grape Powder (GP), Extractable Polyphenol (EP) 
Fraction and Non-extractable Polyphenol (NEP) Fraction 
 
Assay GP EP NEP 
Weight percentage (%) 100 2.26 6.91 
Total phenolics
1
  9.13 180.0 ± 1.3  10.5 ± 1.02 
Total anthocyanins
2
  0.33 37.8 ± 1.8 ND 
Total proanthocyanidins
3
 (mg/g) 3.05 305.5 ± 7.0 ND 
 
Total phenolics, mg/g DM as gallic acid equivalent (Folin Ciocaleau assay) 
2
Total anthocyanins, mg/g DM as cyaniding glucoside equivalent (pH differential assay) 
3
Total proanthocyanidins, mg/g DM as cyaniding glucoside equivalent (DMAC assay) 
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Table 4.3. Anthocyanin Concentration in Grape Powder (GP) and the Extractable 
Polyphenol (EP) Fraction 
 
Peak 
# 
Identification GP 
Concentrations 
(mg/kg) 
EP  
Concentrations 
(µ/mg) 
1 Delphinidin-3-O-glucoside   4.93 
2 Pyanidin-3-O-glucoside   10.56 
3 Petunidin-3-O-glucoside   4.91 
4 Peonidin-3-O-glucoside   36.56 
5 Malvidin-3-O-glucoside  145.2 30.83 
6 Malvidin-3-O-(6"-O-acetyl-glucoside)   3.70 
7 Petunidin-3-O-cis-(6"-p-coumaryl-glucoside)   2.56 
8 Cyanidin-3-O-(6"-O-p-coumaryl-glucoside)  125.0 2.21 
9 Petunidin-3-O-trans-(6"-O-p-coumaryl-
glucoside)  
 
3.24 
10 Peonidin-3-O-cis-(6"-p-coumaryl-glucoside  31.7 2.73 
11 Malvidin-3-O-cis(6"-p-coumaryl-glucoside   2.83 
12 Peonidin-3-O-cis-(6"-O-p-coumaryl-glucoside)   28.460 
13 Malvidin-3-O-trans-(6"-O-p-coumaryl-
glucoside)  
 
4.93 
 Total anthocyanins  133.52 
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Table 4.4. Body Weight Gain (BWG), Food Conversion Efficiency (FCE), and Total Calorie  
Intake per Treatment Group.*  
 
*LF, low fat control; HF, high fat sugar control; GP, grape powder; EP, extractable polyphenol 
fraction; NEP, non-extractable polyphenol fraction. 
  
Diets BWG 
(g) 
FCE 
(per cage, 
g food/g BW) 
Kcal  Intake                  
(per cage) 
LF 11.4±0.5
d 
28.74±1.24
a
 2502.26±82.01
c 
HF 24.8±1.0
a 
13.71±0.35
cd
 3253.91±99.43
a 
EP 17.8±0.9
b 
18.43±0.46
b
 3135.50±165.40
ab 
NEP 20.2±0.9
b 
15.98±0.63
c
 3064.54±121.38
ab 
EP+NEP 15.0±0.9
c 
20.71±1.21
b
 2914.92±63.30
b 
GP 24.9±1.0
a
 13.26±0.31
d
 3144.70±97.74
a 
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Figure 4.1. Proanthocyanin Degree of Polymerization in EP Fraction. NP-HPLC-FLD 
chromatogram (excitation 230 nm, emission 320 nm) for proanthocyanidins showing degree of 
polymerization (DP) in extractable polyphenol (EP) from grapes.
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Figure 4.2. Body Fat Percentages and WAT Depot Weights. Adiposity indices of C57BL/6J 
mice fed a low fat (LF),high fat (HF) diet, or a HF diet containing whole powdered table grapes 
(GP), the extractable polyphenol (EP) fraction from grapes, the non-extractable polyphenol 
(NEP) fraction from grapes, or an equal combination of the EP and NEP fractions (EP+NEP) for 
16 weeks.  Body fat percentages were measured at weeks 6, 11, and 15 using dual energy x-ray 
absorptiometry (DEXA).  At week 16, the inguinal, retroperitoneal, epididymal, and mesenteric 
white adipose tissue (WAT) depots were excised and weighed.  The weights of the inguinal, 
retroperitoneal, epididymal, and mesenteric depots were measured, and their sum labelled total 
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WAT.  Means ± SEM (n = 9-10) without a common lowercase letter differ (p<0.05) using one-
way ANOVA and Student’s test.  
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Figure 4.3. Glucose Tolerance Tests and HOMA-IR Index. (A)Glucose tolerance tests (GTT)s 
, (B) the homeostatic model assessment of insulin resistance (HOMA-IR), and (C)plasma TG 
levels of C57BL/6J mice fed a low fat (LF),high fat (HF) diet, or a HF diet containing whole 
powdered table grapes  (GP), the extractable polyphenol (EP) fraction from grapes, the non-
extractable polyphenol (NEP) fraction from grapes, or an equal combination of the EP and NEP 
fractions (EP+NEP) for 16 weeks.  At weeks 7, 12, and 16, GTTs were conducted on mice fasted 
for 8 h and injected i.p. with a 20% glucose solution.  Fasting plasma insulin was collected at 
week 16 and used to calculate the HOMA-IR index. Data are expressed as total area under the 
curve (AUC) for the GTTs. Means ± SEM (n=9-10) without a common lowercase letter differ 
(p<0.05) using one-way ANOVA and Student’s test. 
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Figure 4.4. Liver Markers of Inflammation and Lipid Metabolism. Liver gene expression of 
markers of inflammation, lipolysis, and lipogenesis in liver of C57BL/6J mice fed a low fat (LF), 
high fat (HF) diet, or a HF diet containing whole powdered table grapes (GP), the extractable 
polyphenol (EP) fraction from grapes, the non-extractable polyphenol (NEP) fraction from 
grapes, or an equal combination of the EP and NEP fractions (EP+NEP) for 16 weeks.  qPCR was 
conducted to measure mRNA abundance of genes associated with hepatic inflammation, 
lipolysis, or lipogenesis. Means ± SEM (n=9-10) without a common lowercase letter differ 
(p<0.05) using one-way ANOVA and Student’s test.   
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Figure 4.5. Liver Weight, Triglycerides, and Oil Red O Staining. (A) Liver weights, (B) liver 
triglyceride content, and (C) Oil red O staining of liver tissue of C57BL/6J mice fed a low fat 
(LF),high fat (HF) diet, or a HF diet containing whole powdered table grapes  (GP), the 
extractable polyphenol (EP) fraction from grapes, the non-extractable polyphenol (NEP) fraction 
from grapes, or an equal combination of the EP and NEP fractions (EP+NEP) for 16 weeks. At 
week 16, liver tissues were excised and frozen in OCT compounds, cut at 5 μm, mounted on 
slides, and stained with Oil red O solution. Means ± SEM (n=9-10) without a common lowercase 
letter differ (p<0.05) using one-way ANOVA and Student’s test. 
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Figure 4.6. Expression of Markers of Inflammation in WAT. The expression of markers of 
inflammation in (A) inguinal and (B)epididymal WAT of C57BL/6J mice fed a low fat (LF),high 
fat (HF) diet, or a HF diet containing whole powdered table grapes  (GP), the extractable 
polyphenol (EP) fraction from grapes, the non-extractable polyphenol (NEP) fraction from 
grapes, or an equal combination of the EP and NEP fractions (EP+NEP) for qPCR was conducted 
to measure mRNA abundance of genes associated with inflammation in inguinal (A; 
subcutaneous) and epididymal (B; visceral) WAT depots. Means ± SEM (n=9-10) without a 
common lowercase letter differ (p<0.05) using one-way ANOVA and Student’s test.  
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Figure 4.7. Expression of Markers of Lipid Metabolism in WAT. The expression of markers 
of lipogenesis, lipolysis, or fatty-acid oxidation in (A) inguinal and (B) epididymal WAT of 
C57BL/6J mice fed a low fat (LF),high fat (HF) diet, or a HF diet containing whole powdered 
table grapes  (GP), the extractable polyphenol (EP) fraction from grapes, the non-extractable 
polyphenol (NEP) fraction from grapes, or an equal combination of the EP and NEP fractions 
(EP+NEP) for 16 weeks.  qPCR was conducted to measure mRNA abundance of genes associated 
with lipogenesis, lipolysis, and fatty-acid oxidation in inguinal (A; subcutaneous) and epididymal 
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(B; visceral) WAT depots. Means ± SEM (n=9-10) without a common lowercase letter differ 
(p<0.05) using one-way ANOVA and Student’s test.  
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Figure 4.8. Expression of Markers of Intestinal Inflammation.  The expression of markers of 
inflammation in the (A) ileum,  (B) proximal colon, and the  (A) activity of myeloperoxidase in 
the mucosa of C57BL/6J mice fed a low fat (LF),high fat (HF) diet, or a HF diet containing whole 
powdered table grapes  (GP), the extractable polyphenol (EP) fraction from grapes, the non-
extractable polyphenol (NEP) fraction from grapes, or an equal combination of the EP and NEP 
fractions (EP+NEP) for 16 weeks.  qPCR was conducted to measure mRNA abundance of genes 
associated with inflammation in ileum mucosa and proximal colon mucosa.  Means ± SEM (n=9-
10) without a common lowercase letter differ (p<0.05) using one-way ANOVA and Student’s t 
test.  
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Figure 4.9. Expression of G-protein Receptors and Glycoproteins in Intestinal Mucosa.  The 
expression  of G-protein receptors (Gpr) 41 and 43, peptide YY (Pyy), and glucagon like protein 
(Glp) were measured as markers of SCFA regulation in the (A) ileum and (B) proximal colon 
mucosa of C57BL/6J mice fed a low fat (LF),high fat (HF) diet, or a HF diet containing whole 
powdered table grapes  (GP), the extractable polyphenol (EP) fraction from grapes, the non-
extractable polyphenol (NEP) fraction from grapes, or an equal combination of the EP and NEP 
fractions (EP+NEP) for 16 weeks.  qPCR was conducted to measure mRNA abundance of genes 
associated with regulation of energy intake in ileum mucosa and proximal colon mucosa.  Means 
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± SEM (n=9-10) without a common lowercase letter differ (p<0.05) using one-way ANOVA and 
Student’s test.   
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CHAPTER V 
EPILOGUE 
 
 
Rationale for Studies 1 and 2 
     Obesity is a rapidly growing health issue in the United States [1].  Of particular concern is its 
positive correlation with chronic diseases associated with the metabolic syndrome; i.e., type 2 
diabetes, hypertension, and hyperlipidemia [2].  Studies have shown that consumption of high fat, 
high sugar diets over an extended period of time results in; (i) increases in cytokines such as 
tumor necrosis (TNF)α, interleukin (IL)-6, and monocyte chemoattractant protein (MCP)-1 
released from white adipose tissue (WAT) [3-5], (ii) recruitment of macrophages to clean up 
necrotic adipocytes due to overstressing of the collagen matrix and vascular tissue [6,7], (iii) 
cytokine-induced reduction of insulin sensitivity leading to hyperglycemia [8], and (iv) ectopic 
fat deposition due hyperlipidemia from the diet and WAT remodeling [reviewed in 9]. Research 
has also demonstrated a correlation between diet-induced obesity and alterations to the intestinal 
environment such as increased intestinal inflammation, decreased gut barrier function, and 
alterations to the gut microbiota [10-12].  Current strategies for suppressing the deleterious 
inflammation association with WAT include reducing calorie intake, increasing physical activity 
levels, pharmacological interventions, and surgery [13].  However, long-term lifestyle changes 
associated with these strategies are often difficult to maintain, thus negating their beneficial 
effects on weight reduction.  Therefore, it is important to find alternatives for combating obesity-
related symptoms that may prove more maintainable and sustainable.  One potential dietary 
strategy to reduce pro-inflammatory and pro-oxidant effects of diets rich in fat is the consumption 
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of grapes, grape products, or supplements containing grape powder or extracts, given their 
inherent abundance of polyphenols, which have reported anti-inflammatory and anti-oxidant 
properties. 
     Currently, research on grapes and grape products (e.g. grape juice, raisins, wine, grape 
extracts, grape powder) has demonstrated that the polyphenols in these products (e.g., 
anthocyanins, quercetin, and resveratrol) possess antioxidant and anti-inflammatory properties 
that are beneficial in protecting the cardiovascular system and attenuating some diet-induced pro-
inflammatory markers [14-18].  However, the mechanism by which polyphenol-rich foods such 
as grapes attenuate obesity-mediated inflammation is still unclear.   Reducing the deleterious 
effects of a high fat (HF) diet on intestine health may be one such potential mechanism.  In 
addition to the polyphenols in grapes, they also contain fiber which is known to improve gut 
barrier function and influence commensal bacterial composition [19-22].  Therefore, I 
investigated the following aims;  
Aim 1.  Determine the impact of consuming California table grapes on intestinal 
health in mice fed an American type diet rich in one type of saturated fat 
(Chapter III); and 
Aim 2. Identify a key fraction of California table grapes that improves markers of 
intestinal inflammation in mice fed an American type diet rich in four types of 
saturated fats (Chapter IV). 
Summary of Results from Studies 1 and 2 
     The results from these two studies varied.  In the first study consuming one or both levels of 
powdered whole grapes (i.e., 3 or 5%, w/w) in conjunction with the HF diet (i.e., 34% kcals from 
fat) rich in butter fat (Chapter III) reduced body fat percentage, the total weight of all four fat 
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depots, or inguinal fat depot weight after 10 wk of treatment.  However, these beneficial effects 
of grape consumption did not equate to improved glucose tolerance.  There was an improvement 
in a marker of gut barrier function (i.e., increased localization of the tight junction protein zonula 
occluden (ZO)-1 on the apical surface of the ileum epithelium) in the ileum by powder grapes 
when compared to their HF fed controls. However, the HF diet did not significantly increase the 
m RNA levels of several proinflammatory genes (e.g., tumor necrosis factor-α (Tnfα), cluster 
differentiation (Cd)11c, mucin-like hormone receptor 1 (Erm1), monocyte chemoattractant 
protein 1 (Mcp1), and toll-like receptor 4 (Tlr4)) or proinflammatory enzymes (e.g., 
myeloperoxidase and alkaline phosphatase)  in intestinal mucosawhen compared to low fat 
controls. High-fat-fed mice consuming grapes had a lower abundance of deleterious sulfidogenic 
bacteria (e.g., decreased mRNA levels of Desulfobacter spp and dsrA genes) when compared to 
controls in the cecum mucosa, and a trend for greater abundance of the beneficial bacteria 
Akkermansia muciniphila in the cecum digesta, colon digesta, or colon mucosa.  High fat feeding 
decreased the relative abundance and variance of bacterial populations compared to low fat 
controls. Consumption of 3% grape powdersimproved variance compared to its respective 
controls.  For example , 3% grape supplementation increased the abundance of Ruminoccocus 
and Anaeroplasma in the Firmicutes and Tenericutes phylum, respectively, along with S24-7 of 
the Bacteriodes phylum compared to the 3% HF sugar controls. Relatively no differences were 
observed between the 5% grape supplementation and its respective controls. Lastly, certain 
beneficial bacteria populations (Bifidobacterium, Lactobacillus, Allobaculum) were inversely 
correlated with body fat mass and inguinal fat depot weights  
     In the second study (Chapter IV), mice were fed a higher level of fat (i.e., 45% kcals from fat) 
containing a mixture of saturated fat sources (i.e., lard, beef tallow, shortening, and butter) that 
more closely represented the American diet (i.e., 75
th
 percentile according to [23]). This higher 
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level of fat was given for 16 weeks in order to determine if it would increase intestinal and 
systemic inflammation, because such pro-inflammatory effects were not observed in the first 
study after 10 wk of feeding a HF diet (35% kcal) primarily composed of butter.  These HF fed 
mice were given one of three fractions; i.e., a methanol-extractable, polyphenol-rich fraction 
(EP), a non-extractable, polyphenol-poor, fiber rich fraction (NEP), and the combination of both 
fractions (EP + NEP). The levels of EP and NEP given were similar to those found in the 5% 
grape diet using in the first study.  A 5% grape diet was also fed to mice, based on the outcomes 
of the first study.  
     Notably, the EP fraction alone or in combination with NEP (EP+NEP) reduced body fat 
percentage, total body fat depot weights, and inguinal, mesenteric, and epididymal fat depot 
weights when compared to the HF controls. Rates of glucose disposal and the HOMA-IR score 
were also improved in the EP and EP+NEP groups compared to the HF controls.  Lastly, the 
mRNA levels of several inflammatory genes in WAT were lower in the EP and EP+NEP group 
compared to the HF controls.  Surprisingly, the 5% grape diet did not reduce adiposity, as in 
Study 1, and it actually impaired glucose disposal compared to the mice fed the HF diet alone.   
     Similar to the first study, no markers of inflammation were upregulated in the ileum by HF 
diet alone; however grape powder did significantly increase the expression of Tlr4 and Cd68,  but 
not others (e.g., Tnfα, Cd11c, Mcp1, and inter-leukin (Il)1-β).  In the proximal colon, HF diet 
increased the expression of Cd11c and Cd68, with only EP+NEP attenuating the expression of 
Cd68.  Grape powder once again increased the expression of Tlr4.  However, G-protein receptor 
(Gpr) 43 expression was up regulated by the grape fraction diets (EP, NEP, and EP+NEP), 
indicating that ligands for this receptor (e.g., short chain fatty acids (SCFA)) may have been 
increased in the ileum. However, data on SCFA abundance, ZO-1 localization, and microbiota 
profiles are not currently available. 
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Interpretations and Implications for the Results from Study 1 and 2 
Potential reasons for the differential effects of the whole grape diets  
      Taken together, these results indicate that the beneficial systemic effects of consuming grapes 
in first study (Chapter III) and the EP fraction in the second study (Chapter IV) may be due to 
their rich polyphenol content.  The results of the second study, however, did not demonstrate the 
same beneficial systemic effects from consuming the powdered grapes as were seen in the first 
study.  There were several differences in the design of the two studies that may have contributed 
to these conflicting results; (1) the length of the study- 10 weeks versus 16 weeks, (2) the fat 
composition- primarily from butter versus from butter, lard, shortening, and beef tallow, (3) the 
percentage of kilocalories from fat- 34% kcals versus 45% kcals, and (4) the amount of fiber (50 
g and 40 g cellulose respectively). The length of study 2 was 6 weeks longer than study 1, which 
may have caused any potential health benefits of the whole grape diet to have diminished.  Yet, 
by week 10 of study 2, there were no differences between the HF and grape powder group in 
regards to body weight, body fat percentage, and glucose tolerance.  As previously mentioned, the 
first study focused on a single saturated fat type (i.e., butter) while the second study was a mixed 
saturated fat diet (i.e., butter, lard, shortening, and beef tallow) more representative in 
composition to the American diet. As a result, there may have been a different interaction 
between the powdered grapes and the four types of fats in the second study 2; (i.e., the 
polyphenols in the powder grapes may interact with milk fat differently than with the other fat 
sources).  Such an interaction may have enabled the polyphenols to inhibit lipase activity, 
possibly affecting the rate of fat absorption.  The second study contained a higher percentage of 
fat (45% kcals) then the first study (34% kcals).  It is likely that the increase in calories was too 
excessive for the beneficial effects of the whole food to have a positive impact on lipid 
absorption.  In order to increase the percentage of fat in the second study, the amount of fiber was 
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reduced compared to the first study (i.e., cellulose was reduced by 10 g and corn starch was 
reduced by 120 g).The alteration in carbohydrate and fiber content may have resulted in more 
time in transit, allowing more time for increased absorption of macronutrients. Such a scenario 
would result in greater energy harvest, adipogenesis, and triglyceride synthesis in the liver and 
WAT, independent of any effects by the grape powder.   
     Another possible impact of the reduced fiber may have been on the microbiota of the large 
intestine, as fiber is a primary energy source for a vast majority of microbes in this environment.  
As such, the reduced fiber may impact the production of SCFAs as well as reduce the diversity of 
the microbiota which typically results in intestinal inflammation or adverse systemic effects.  
Interestingly, although the powdered grapes had no positive health impact in the second study, the 
extractable polyphenol fraction did have a positive effect on reducing high-fat-mediated adiposity 
and systemic inflammation.    
 
Potential reasons for the beneficial effects of the EP fraction  
     I speculate that the acidified-methanol used to extract the polyphenols in the second study may 
have improved the bioaccessibility and thus bioavailibity of the polyphenols in grapes.  This may 
have increased the beneficial effects of the liberated polyphenols in several ways that would not 
have been as effective as part of the whole grape.  The EP fraction, which is rich in anthocyanins, 
may have impacted lipid absorption by interacting with lipid droplets, increasing the size of the 
hydroscopic outer layer of the droplet yet reducing the surface area for interaction with pancreatic 
lipases.  This would directly impact the intestinal absorption of fat, thus reducing the amount of 
free fatty acids available for triglyceride synthesis, chylomicron packaging, and subsequent 
storage in WAT.  Lipids may also bind to polyphenols and protect them from metabolism in the 
intestine, thus improving their bioavailability.  As the polyphenols in the EP fraction are not 
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bound to other components as they are in the whole grape, they would be able to bind to the lipids 
and thus increase their concentrations systemically.   
     The antioxidant properties of the polyphenols in the EP fractions may also have been 
enhanced following extraction; i.e., once they were separated from the matrices within the whole 
grape by the acidified methanol.  This may have aided in reducing any deleterious effects of 
potential lipid peroxidation produced during the digestive process.  As polyphenols are poorly 
absorbed (e.g., 1-5%), these changes may have been a result of colonic microbial interaction with 
the extracted polyphenols.  This may have led to alterations in the intestinal microbiota that could 
have improved the concentration of beneficial bacteria (i.e., Bacteriodetes or Lactobacillus) and 
reduce that of deleterious bacteria (i.e., Firmicutes or Clostridium) [24-28].  The increase in 
products of the beneficial bacteria, namely the production of SCFAs, may have resulted in 
improved insulin sensitivity and satiety through interaction with G-protein receptors located on 
enteroendocrine cells.  Consistent with this hypothesis, Gpr43 mRNA levels were higher in the 
EP, NEP, and EP+NEP groups compared to the HF controls.   However, the contribution of gut 
microbes to these systemic health benefits is still speculative, because of the minimal impact of 
the HF diets and grapes on markers of intestinal health.  Similarly, it is unclear whether or not 
powdered grapes or their extracts improve intestinal health, and if such changes translate into 
improvements observed in weight, body fat percentage, and systemic markers of inflammation 
and lipid metabolism assessed by my collaborator Jessie Baldwin. 
 
Research questions based on results 
     Based on these findings, I have developed the following research questions; (i) What effects 
would grape consumption have on intestinal inflammation and microbiota in a model of induced 
colitis using a chemical agent (e.g., dextran sulfate sodium) or in a genetic model (e.g., IL10 
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knockout) mouse models?, (ii) What effects would grape consumption have on intestinal 
inflammation and microbiota of C57BL/6J mice fed 60% kcals from fat?, (iii) What effect would 
grape consumption have in concert with a probiotic on the intestinal health, microbiome 
composition, and SCFA production in the intestine of mice fed a HF diet?, (iv) What effects 
would the EP fraction compared to whole grapes have in the previous three models mentioned 
above?, (v) What impact would EP fraction have on the growth, differentiation, or mucin 
secretion of  goblet cells (endothelial mucin secreting cells) and HT29 cells (human colonic 
adenocarcinoma cells that are able to differentiate into mature intestinal cells)?, (vi) What impact 
would the EP fraction have on the growth of beneficial bacteria like Lactobacillus acidophilus, L. 
plantarum, L. delbruekii, or Akkermansia muciniphila in culture?, (vii) Would culturing the 
microbiota from the cecum of mice fed extractable polyphenols with known prebiotics/probiotics 
produce an exponential increase in beneficial products compared the cecum microbiota of mice 
fed a control diet and similarly treated?, (viii) Would individual anthocyanins, alone or in 
combination, that are abundant in the EP fraction have a greater effect on intestinal and systemic 
inflammation in mice then the EP itself?, and (ix) What would be the potential mechanisms for 
the attenuation of systemic inflammation and insulin resistance in mice fed a HF diet 
supplemented with the  EP fraction or candidate polyphenols? 
     Future analysis for the second study will involve exploration of the potential anti-oxidant 
effects of powdered grapes and the EP fraction.  This will be done by measuring the mRNA or 
activity levels of enzymes associated with anti-oxidant related transcription factor NF-E2-related 
factor-2 (e.g., superoxide dismutase 2, glutathione peroxidase 2, heme oxygenase 1, and 
glutamate-cysteine ligase, catalytic subunit) which are known to combat oxidative stress through 
reduction of reactive oxygen species. These results along with future research studies conducted 
to answer my proposed questions could be critical in providing a better understanding of the 
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interaction between microbiota, polyphenols, and intestinal and systemic inflammation. In so 
doing, it is possible that a new area of dietary intervention could be established in regards to 
chronic inflammatory diseases.  My research has demonstrated that grapes and their extracted 
polyphenols may improve health outcomes, depending on the level and type of fat calories.  As 
such, implementing effective dietary strategies using grapes or their extracted polyphenols would 
have the benefit of reducing health care cost and loss of productivity associated with obesity and 
subsequent comorbidities.    
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Figure 5.1. A Model of the Anthropometric and Intestinal Measurements Recorded in 
Study 1 and Study 2.  zonula occludin (ZO)-1, grape powder (GP), homeostasis model 
assessment-estimated insulin resistance (HOMA-IR), extractable polyphenol fraction (EP), non-
extractable polyphenol fraction (NEP), G-Protein receptor (GPR), toll-like receptor (TLR)4, 
cluster of differentiation (CD), proximal (P.).  
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